Global Medical REIT (GMRE) 10-Q 7 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 01, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Entity Registrant Name	Global Medical REIT Inc.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Central Index Key	0001533615
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Trading Symbol	GMRE
Entity Common Stock, Shares Outstanding		36,371,564
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Small Business	true

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Investment in real estate:
Land	$ 86,878	$ 63,710
Building	637,505	518,451
Site improvements	9,100	6,880
Tenant improvements	31,465	15,357
Acquired lease intangible assets	65,498	43,152
Real Estate Investment Property, at Cost, Total	830,446	647,550
Less: accumulated depreciation and amortization	(48,731)	(30,625)
Investment in real estate, net	781,715	616,925
Cash and cash equivalents	2,815	3,631
Restricted cash	3,011	1,212
Tenant receivables	4,167	2,905
Due from Related Parties	75
Escrow deposits	2,865	1,752
Deferred assets	13,307	9,352
Other assets	4,363	322
Total assets	812,318	636,099
Liabilities:
Credit facility, net of unamortized discount of $3,983 and $3,922 at September 30, 2019 and December 31, 2018, respectively	363,242	276,353
Notes payable, net of unamortized discount of $701 and $799 at September 30, 2019 and December 31, 2018, respectively	38,651	38,654
Accounts payable and accrued expenses	5,501	3,664
Dividends payable	9,470	6,981
Security deposits and other	6,362	4,152
Due to related parties, net	1,584	1,030
Derivative liability	10,399	3,487
Other liability	2,379
Acquired lease intangible liability, net	3,287	2,028
Total liabilities	440,875	336,349
Commitments and contingencies
Equity:
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at September 30, 2019 and December 31, 2018, respectively (liquidation preference of $77,625 at September 30, 2019 and December 31, 2018, respectively)	74,959	74,959
Common stock, $0.001 par value, 500,000 shares authorized; 36,290 shares and 25,944 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively	36	26
Additional paid-in capital	340,435	243,038
Accumulated deficit	(63,846)	(45,007)
Accumulated other comprehensive loss	(10,596)	(3,721)
Total Global Medical REIT Inc. stockholders' equity	340,988	269,295
Noncontrolling interest	30,455	30,455
Total equity	371,443	299,750
Total liabilities and equity	$ 812,318	$ 636,099

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Debt Instrument, Unamortized Discount	$ 701	$ 799
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	3,105	3,105
Preferred stock, shares outstanding	3,105	3,105
Preferred Stock, Liquidation Preference, Value	$ 77,625	$ 77,625
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	500,000	500,000
Common stock, shares issued	36,290	25,944
Common stock, shares outstanding	36,290	25,944
Revolving credit facility [Member]
Debt Instrument, Unamortized Discount	$ 3,983	$ 3,922
Notes Payable [Member]
Debt Instrument, Unamortized Discount	$ 701	$ 799

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue
Rental revenue	$ 18,117	$ 13,995	$ 50,093	$ 38,790
Other income	78	8	182	27
Total revenue	18,195	14,003	50,275	38,817
Expenses
General and administrative	1,681	1,395	4,928	4,169
Operating expenses	1,362	941	3,826	2,726
Management fees - related party	1,621	1,104	4,539	3,280
Depreciation expense	5,006	3,614	13,481	9,965
Amortization expense	1,500	953	3,757	2,645
Interest expense	4,549	4,055	12,707	10,681
Preacquisition fees	168	168	224	294
Total expenses	15,887	12,230	43,462	33,760
Net income	2,308	1,773	6,813	5,057
Less: Preferred stock dividends	(1,455)	(1,455)	(4,366)	(4,366)
Less: Net income attributable to noncontrolling interest	(83)	(32)	(246)	(59)
Net income attributable to common stockholders	$ 770	$ 286	$ 2,201	$ 632
Net income attributable to common stockholders per share - basic and diluted	$ 0.02	$ 0.01	$ 0.07	$ 0.03
Weighted average shares outstanding - basic and diluted	35,512	21,797	32,514	21,687

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Condensed Consolidated Statements of Comprehensive (Loss) Income
Net income	$ 2,308	$ 1,773	$ 6,813	$ 5,057
Other comprehensive loss:
Decrease in fair value of interest rate swap agreement	(1,303)	(109)	(6,875)	(109)
Total other comprehensive loss	(1,303)	(109)	(6,875)	(109)
Comprehensive income (loss)	1,005	1,664	(62)	4,948
Less: Preferred stock dividends	(1,455)	(1,455)	(4,366)	(4,366)
Less: Comprehensive loss (income) attributable to noncontrolling interest	44	(21)	442	(48)
Comprehensive (loss) income attributable to common stockholders	$ (406)	$ 188	$ (3,986)	$ 534

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Global Medial REIT Inc. Stockholders' Equity [Member]	Noncontrolling Interest [Member]	Total
Balances at Dec. 31, 2017	$ 22	$ 74,959	$ 205,788	$ (34,434)	$ 0	$ 246,335	$ 12,678	$ 259,013
Balance (in shares) at Dec. 31, 2017	21,631	3,105
Net income	$ 0	$ 0	0	4,998	0	4,998	59	5,057
Issuance of shares of common stock, net	$ 0	$ 0	3,452	0	0	3,452	0	3,452
Issuance of shares of common stock, net (in shares)	372	0
Reclassification of deferred offering costs	$ 0	$ 0	(302)	0	0	(302)	0	(302)
Change in fair value of interest rate swap agreements	0	0	0	0	(109)	(109)	0	(109)
Stock-based compensation expense	0	0	0	0	0	0	1,978	1,978
Dividends to common stockholders	0	0	0	(13,053)	0	(13,053)	0	(13,053)
Dividends to preferred stockholders	0	0	0	(4,366)	0	(4,366)	0	(4,366)
Dividends to noncontrolling interest	0	0	0	0	0	0	(1,493)	(1,493)
OP Units issued to third parties	0	0	0	0	0	0	4,742	4,742
LTIP Units redeemed for cash	0	0	0	0	0	0	(263)	(263)
Balances at Sep. 30, 2018	$ 22	$ 74,959	208,938	(46,855)	(109)	236,955	17,701	254,656
Balances (in shares) at Sep. 30, 2018	22,003	3,105
Balances at Dec. 31, 2017	$ 22	$ 74,959	205,788	(34,434)	0	246,335	12,678	259,013
Balance (in shares) at Dec. 31, 2017	21,631	3,105
Balances at Dec. 31, 2018	$ 26	$ 74,959	243,038	(45,007)	(3,721)	269,295	30,455	299,750
Balances (in shares) at Dec. 31, 2018	25,944	3,105
Balances at Jun. 30, 2018	$ 22	$ 74,959	205,798	(42,739)	0	238,030	17,483	255,513
Balance (in shares) at Jun. 30, 2018	21,631	3,105
Net income	$ 0	$ 0	0	1,741	0	1,741	32	1,773
Issuance of shares of common stock, net	$ 0	$ 0	3,452	0	0	3,452	0	3,452
Issuance of shares of common stock, net (in shares)	372	0
Reclassification of deferred offering costs	$ 0	$ 0	(302)	0	0	(302)	0	(302)
Change in fair value of interest rate swap agreements	0	0	0	0	(109)	(109)	0	(109)
Stock-based compensation expense	0	0	0	0	0	0	741	741
Dividends to common stockholders	0	0	0	(4,402)	0	(4,402)	0	(4,402)
Dividends to preferred stockholders	0	0	0	(1,455)	0	(1,455)	0	(1,455)
Dividends to noncontrolling interest	0	0	0	0	0	0	(555)	(555)
Balances at Sep. 30, 2018	$ 22	$ 74,959	208,938	(46,855)	(109)	236,955	17,701	254,656
Balances (in shares) at Sep. 30, 2018	22,003	3,105
Balances at Dec. 31, 2018	$ 26	$ 74,959	243,038	(45,007)	(3,721)	269,295	30,455	299,750
Balance (in shares) at Dec. 31, 2018	25,944	3,105
Net income	$ 0	$ 0	0	6,567	0	6,567	246	6,813
Issuance of shares of common stock, net	$ 10	$ 0	96,767	0	0	96,777	0	96,777
Issuance of shares of common stock, net (in shares)	10,284	0
LTIP Units and OP Units redeemed for common stock	$ 0	$ 0	630	0	0	630	(630)	0
LTIP Units and OP Units redeemed for common stock (in shares)	62	0
Change in fair value of interest rate swap agreements	$ 0	$ 0	0	0	(6,875)	(6,875)	0	(6,875)
Stock-based compensation expense	0	0	0	0	0	0	2,493	2,493
Dividends to common stockholders	0	0	0	(21,040)	0	(21,040)	0	(21,040)
Dividends to preferred stockholders	0	0	0	(4,366)	0	(4,366)	0	(4,366)
Dividends to noncontrolling interest	0	0	0	0	0	0	(2,615)	(2,615)
OP Units issued to third parties	0	0	0	0	0	0	506	506
Balances at Sep. 30, 2019	$ 36	$ 74,959	340,435	(63,846)	(10,596)	340,988	30,455	371,443
Balances (in shares) at Sep. 30, 2019	36,290	3,105
Balances at Jun. 30, 2019	$ 35	$ 74,959	322,872	(57,397)	(9,293)	331,176	30,427	361,603
Balance (in shares) at Jun. 30, 2019	34,653	3,105
Net income	$ 0	$ 0	0	2,225	0	2,225	83	2,308
Issuance of shares of common stock, net	$ 1	0	17,509	0	0	17,510	0	17,510
Issuance of shares of common stock, net (in shares)	1,632
LTIP Units and OP Units redeemed for common stock	$ 0	0	54	0	0	54	(54)	0
LTIP Units and OP Units redeemed for common stock (in shares)	5
Change in fair value of interest rate swap agreements	$ 0	0	0	0	(1,303)	(1,303)	0	(1,303)
Stock-based compensation expense	0	0	0	0	0	0	868	868
Dividends to common stockholders	0	0	0	(7,219)	0	(7,219)	0	(7,219)
Dividends to preferred stockholders	0	0	0	(1,455)	0	(1,455)	0	(1,455)
Dividends to noncontrolling interest	0	0	0	0	0	0	(869)	(869)
Balances at Sep. 30, 2019	$ 36	$ 74,959	$ 340,435	$ (63,846)	$ (10,596)	$ 340,988	$ 30,455	$ 371,443
Balances (in shares) at Sep. 30, 2019	36,290	3,105

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating activities
Net income	$ 6,813	$ 5,057
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense	13,481	9,965
Amortization of acquired lease intangible assets	3,757	2,645
Amortization of above market leases, net	634	484
Amortization of deferred financing costs and other	1,000	1,327
Stock-based compensation expense	2,493	1,978
Capitalized preacquisition costs charged to expense	162	132
Other	82
Changes in operating assets and liabilities:
Tenant receivables	(1,232)	(1,040)
Deferred assets	(3,955)	(4,597)
Other assets	(154)	(126)
Accounts payable and accrued expenses	911	1,434
Security deposits and other	2,210	1,800
Accrued management fees due to related party	479	41
Net cash provided by operating activities	26,681	19,100
Investing activities
Purchase of land, buildings, and other tangible and intangible assets and liabilities	(181,440)	(133,851)
Escrow deposits for purchase of properties	(897)	(774)
Loans to related parties		(49)
Capital expenditures on existing real estate investments	(337)	(2,014)
Preacquisition costs		257
Net cash used in investing activities	(182,674)	(136,431)
Financing activities
Net proceeds received from common equity offerings	96,799	3,209
Escrow deposits required by third party lenders	(216)	(216)
Repayment of note payable	(101)
Proceeds from Credit Facility	164,450	142,900
Repayment of Credit Facility	(77,500)	(10,400)
Payments of deferred financing costs	(924)	(2,750)
Redemption of LTIP Units		(263)
Dividends paid to common stockholders, and OP Unit and LTIP Unit holders	(21,167)	(14,075)
Dividends paid to preferred stockholders	(4,365)	(4,366)
Net cash provided by financing activities	156,976	114,039
Net increase (decrease) in cash and cash equivalents and restricted cash	983	(3,292)
Cash and cash equivalents and restricted cash-beginning of period	4,843	7,114
Cash and cash equivalents and restricted cash-end of period	5,826	3,822
Supplemental cash flow information:
Cash payments for interest	11,687	9,106
Noncash financing and investing activities:
Accrued dividends payable	9,470	5,995
Initial recognition of lease liability related to right of use asset	3,143
OP Units issued for property acquisition	506	4,742
Accrued common stock offering costs	22	302
LTIP Units and OP Units redeemed for common stock	630
Accrued pre acquisition costs for purchase of properties and tenant improvements	901	774
Construction in Progress [Member]
Noncash financing and investing activities:
Construction-in-process completed and transferred to real estate investments	100	2,043
Interest Rate Swap [Member]
Noncash financing and investing activities:
Interest rate swap agreements fair value change recognized in other comprehensive loss	$ 6,875	$ 109

Organization

Organization	9 Months Ended
	Sep. 30, 2019
Organization
Organization	Note 1 – Organization Global Medical REIT Inc. (the “Company”) is a Maryland corporation engaged primarily in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to strong healthcare systems and physician groups with leading market share. The Company is externally managed and advised by Inter-American Management, LLC (the “Advisor”), a Delaware limited liability company and an affiliate of the Company. The Company holds its facilities and conducts its operations through a Delaware limited partnership subsidiary named Global Medical REIT L.P. (the “Operating Partnership”). The Company serves as the sole general partner of the Operating Partnership through a wholly-owned subsidiary of the Company named Global Medical REIT GP LLC, a Delaware limited liability company. As of September 30, 2019, the Company was the 90.22% limited partner of the Operating Partnership, with an aggregate of 9.78% of the Operating Partnership owned by holders of long-term incentive plan units (“LTIP Units”) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for common limited partnership units (“OP Units”).

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Basis of presentation The accompanying condensed consolidated financial statements are unaudited and include the accounts of the Company, the Operating Partnership and its wholly-owned subsidiaries. The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual consolidated financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, the accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended December 31, 2018. In the opinion of management, all adjustments of a normal and recurring nature necessary for a fair presentation of the condensed consolidated financial statements for the interim periods have been made. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company, including the Operating Partnership and its wholly-owned subsidiaries. The Company presents the portion of any equity it does not own but controls (and thus consolidates) as noncontrolling interest. Noncontrolling interest in the Company includes the LTIP Units that have been granted to the Company’s and Advisor’s directors, officers and employees and the OP Units held by third parties. Refer to Note 5 – “Equity” and Note 7 – “Stock-Based Compensation” for additional information regarding the OP Units and LTIP Units. The Company classifies noncontrolling interest as a component of consolidated equity on its Condensed Consolidated Balance Sheets, separate from the Company’s total equity. The Company’s net income or loss is allocated to noncontrolling interests based on the respective ownership or voting percentage in the Operating Partnership associated with such noncontrolling interests and is removed from consolidated income or loss on the Condensed Consolidated Statements of Operations in order to derive net income or loss attributable to common stockholders. The noncontrolling ownership percentage is calculated by dividing the aggregate number of LTIP Units and OP Units held by third parties by the total number of shares of common stock, LTIP Units and OP Units outstanding. Any future issuances of additional shares of common stock, LTIP Units or OP Units could change the noncontrolling ownership interest. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Actual results could differ from those estimates. Investment in Real Estate The Company determines when an acquisition meets the definition of a business or alternatively should be accounted for as an asset acquisition in accordance with ASU 2017-01 – “Business Combinations (Topic 805): Clarifying the Definition of a Business” (“ASU 2017-01”). ASU 2017-01 requires that, when substantially all of the fair value of an acquisition is concentrated in a single identifiable asset or a group of similar identifiable assets, the asset or group of similar identifiable assets does not meet the definition of a business and therefore is required to be accounted for as an asset acquisition. Transaction costs are capitalized for asset acquisitions and expensed as incurred for business combinations. ASU 2017-01 results in most, if not all, of the Company’s acquisitions being accounted for as asset acquisitions because substantially all of the fair value of the gross assets the Company acquires are concentrated in a single asset or group of similar identifiable assets. For asset acquisitions that are “owner occupied” (meaning that the seller either is the tenant or controls the tenant), the purchase price, including capitalized acquisition costs, will be allocated to land and building based on their relative fair values with no value allocated to intangible assets or liabilities. For asset acquisitions where there is a lease in place but not “owner occupied,” the Company will also allocate the purchase price to tangible assets and any intangible assets acquired or liabilities assumed based on their relative fair values. Real estate and related assets are stated net of accumulated depreciation. Renovations, replacements and other expenditures that improve or extend the life of assets are capitalized and depreciated over their estimated useful lives. Expenditures for ordinary maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful life of the buildings, which are generally between 23 and 50 years, tenant improvements, which are generally between one and 19 years, and site improvements, which are generally between three and 14 years. Revenue Recognition The Company’s operations primarily consist of rental revenue earned from tenants under leasing arrangements which provide for minimum rent and escalations. The leases have been accounted for as operating leases. For operating leases with contingent rental escalators, revenue is recorded based on the contractual cash rental payments due during the period. Revenue from leases with fixed annual rental escalators are recognized on a straight-line basis over the initial lease term, subject to a collectability assessment, with the difference between the contractual rental receipts and the straight-line amounts recorded as a “deferred rent receivable.” Additionally, rental revenue includes expense recoveries, which represents revenue recognized related to tenant reimbursement of real estate taxes, insurance, and certain other operating expenses. The Company recognizes these reimbursements and related expenses on a gross basis in its Condensed Consolidated Statements of Operations. Expenses required to be paid directly by the tenant are not subject to reimbursement. For all leases where rent collection has been deemed probable, the Company assesses the need for an allowance for doubtful accounts, including an allowance for operating lease straight-line rent receivables, for estimated losses resulting from tenant defaults, or the inability of tenants to make contractual rent and tenant recovery payments at each reporting date. The Company also monitors the liquidity and creditworthiness of its tenants and operators on a continuous basis. This evaluation considers industry and economic conditions, property performance, credit enhancements and other factors. For operating lease straight-line rent amounts, the Company's assessment is based on amounts estimated to be recoverable over the term of the lease. As of September 30, 2019 and December 31, 2018, based on the Company’s assessment, no allowance was recorded as one was not deemed necessary. However, because future events may adversely affect the Company’s tenants, a valuation allowance may need to be established in the future. Cash and Cash Equivalents and Restricted Cash The Company considers all demand deposits, cashier’s checks, money market accounts, and certificates of deposit with an original maturity of three months or less to be cash equivalents. Amounts included in restricted cash represent (1) certain security deposits received from tenants at the inception of their leases; (2) cash required to be held by a third-party lender as a reserve for debt service; and (3) funds held by the Company that were received from certain tenants that the Company collected to pay specific tenant expenses, such as real estate taxes and insurance, on the tenant’s behalf (“tenant reimbursements”). The following table provides a reconciliation of the Company’s cash and cash equivalents and restricted cash that sums to the total of those amounts at the end of the periods presented on the Company’s accompanying Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019 and 2018: As of September 30, 2019 2018 Cash and cash equivalents $ 2,815 $ 3,005 Restricted cash 3,011 817 Total cash and cash equivalents and restricted cash $ 5,826 $ 3,822 Escrow Deposits The escrow deposits balance as of September 30, 2019 and December 31, 2018 was $2,865 and $1,752, respectively. Escrow deposits include funds held in escrow to be used for the acquisition of properties in the future and for the payment of taxes, insurance, and other amounts as stipulated by the Company’s Cantor Loan, as hereinafter defined. Deferred Assets The deferred assets balance as of September 30, 2019 and December 31, 2018 was $13,307 and $9,352, respectively. The balance as of September 30, 2019 consisted of $13,020 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and $287 of other deferred costs. The balance as of December 31, 2018 consisted of $8,706 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and $646 of other deferred costs. Other Assets The other assets balance was $4,363 as of September 30, 2019, which consisted of $3,094 for a right of use asset that was recorded in connection with the implementation of ASC Topic 842 on January 1, 2019 (refer to Note 8 – “Leases” for additional details), $930 in deferred preacquisition and construction in process costs, and $339 in a prepaid asset. The other assets balance was $322 as of December 31, 2018, which consisted of $139 in capitalized costs related to property acquisitions and $183 in a prepaid asset. Security Deposits and Other The security deposits and other liability balance as of September 30, 2019 and December 31, 2018 was $6,362 and $4,152, respectively. The balance as of September 30, 2019 consisted of security deposits of $4,942 and a tenant impound liability of $1,420 related to amounts owed for specific tenant expenses. The balance as of December 31, 2018 consisted of security deposits of $3,272 and a tenant impound liability of $880 related to amounts owed for specific tenant expenses. Derivative Instruments - Interest Rate Swaps As of September 30, 2019 and December 31, 2018, the Company had three interest rate swaps that were designated as cash flow hedges of interest rate risk. In accordance with the Company’s risk management strategy, the purpose of the interest rate swaps is to manage interest rate risk for a portion of the Company’s variable-rate debt. The interest rate swaps involve the Company’s receipt of variable-rate amounts from three counterparties in exchange for the Company making fixed-rate payments over the life of the agreement. The Company accounts for derivative instruments in accordance with the provisions of ASC Topic 815, “Derivatives and Hedging” and ASU No. 2017‑12, “Derivatives and Hedging: Targeted Improvements to Accounting for Hedging Activities.” As of September 30, 2019 and December 31, 2018, the Company’s liability balance related to these interest rate swaps was $10,399 and $3,487, respectively. Refer to Note 4 – “Credit Facility, Notes Payable and Derivative Instruments” for additional details regarding these interest rate swaps. Additionally, as discussed in Note 11 - "Subsequent Events," on October 3, 2019, the Company executed two additional interest rate swaps with a combined notional amount of $130 million. Other Liability The Company adopted ASC Topic 842 on January 1, 2019, and had an other liability balance of $2,379 as of September 30, 2019, based on the provisions of that standard (refer to Note 8 – “Leases” for additional details). Reclassification The Company reclassified the line item “Expense Recoveries” on its Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2018, of $884 and $2,610, respectively, to present this amount as a component of “Rental Revenue,” in order to conform to the current period presentation.

Property Portfolio

Property Portfolio	9 Months Ended
	Sep. 30, 2019
Property Portfolio
Property Portfolio	Note 3 – Property Portfolio Summary of Properties Acquired During the Nine Months Ended September 30, 2019 During the nine months ended September 30, 2019 the Company completed 13 acquisitions. For each acquisition, substantially all of the fair value was concentrated in a single identifiable asset or group of similar identifiable assets and, therefore, each acquisition represents an asset acquisition. Accordingly, transaction costs for these acquisitions were capitalized. A rollforward of the gross investment in land, building and improvements as of September 30, 2019 resulting from these acquisitions as well as other tenant improvements and the implementation of ASC 842 is as follows: Site & Tenant Acquired Lease Gross Investment in Land Building Improvements Intangible Assets Real Estate Balances as of December 31, 2018 $ 63,710 $ 518,451 $ 22,237 $ 43,152 $ 647,550 Facility Acquired – Date Acquired: Zachary – 2/28/19 — 3,336 512 835 4,683 Gilbert and Chandler – 3/19/19 4,616 11,643 — — 16,259 Las Vegas – 4/15/19 2,479 15,277 2,449 2,297 22,502 Oklahoma Northwest – 4/15/19 2,364 19,501 3,187 3,155 28,207 Mishawaka – 4/15/19 1,924 10,084 1,872 2,223 16,103 Surprise – 4/15/19 1,738 18,737 4,347 3,860 28,682 San Marcos – 7/12/19 2,322 6,934 530 2,188 11,974 Lansing – 8/1/19 1,202 7,681 852 1,633 11,368 Bannockburn – 8/5/19 731 3,419 1,214 1,325 6,689 Aurora – 8/6/19 1,521 7,446 911 2,679 12,557 Livonia – 8/14/19 980 7,629 643 1,340 10,592 Gilbert – 8/23/19 2,408 2,027 424 733 5,592 Morgantown – 9/26/19 883 5,286 879 902 7,950 ASC 842 Reclassification — — — (824) (824) Site and Tenant improvements (1) — — 508 — 508 Capitalized costs (2) — 54 — — 54 Total Additions: 23,168 119,054 18,328 22,346 182,896 Balances as of September 30, 2019 $ 86,878 $ 637,505 $ 40,565 $ 65,498 $ 830,446 (1) Represents tenant improvements that were completed and placed in service during the nine months ended September 30, 2019 related to the Sherman facility that was acquired in June 2017 and the Bountiful facility that was acquired in October 2018. Also includes site improvements at the Watertown facility that was acquired in September 2016. (2) Represents capitalized costs incurred during the nine months ended September 30, 2019 at the Derby facility that was acquired in August 2018. Depreciation expense was $5,006 and $13,481 for the three and nine months ended September 30, 2019, respectively, and $3,614 and $9,965 for the three and nine months ended September 30, 2018, respectively. As of September 30, 2019, the Company had aggregate capital improvement commitments and obligations to improve, expand, and maintain the Company’s existing facilities of $19,137. Many of these amounts are subject to contingencies that make it difficult to predict when they will be utilized, if at all. In accordance with the terms of the Company’s leases, capital improvement obligations in the next 12 months could total up to approximately $10,867. The following is a summary of the acquisitions completed during the nine months ended September 30, 2019. The purchase price allocations are preliminary and subject to revision within the measurement period, not to exceed one year from the date of the acquisition. Zachary Facility On February 28, 2019, the Company assumed the following leasehold interests in the real property located in Zachary, Louisiana for a purchase price of $4.6 million: (i) the interest, as ground lessee, in an existing ground lease of the facility, with approximately 46 years remaining in the initial term with no extension options; and (ii) the interest, as landlord, in an existing lease of the facility with LTAC Hospital of Feliciana, LLC, as tenant, with approximately 16 years remaining in the initial term, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 103 Building and tenant improvements 3,745 In-place leases 305 Above-market lease intangibles 117 Leasing costs 413 Below-market lease intangibles (34) Total purchase price $ 4,649 Gilbert and Chandler Facilities On March 19, 2019, the Company purchased the following facilities located in Gilbert, Arizona and Chandler, Arizona for a total purchase price of $16.3 million: (i) a medical office building located in Gilbert, Arizona; (ii) a medical office building located in Gilbert, Arizona; (iii) a medical office suite located in Chandler, Arizona; and (iv) a medical office suite located in Chandler, Arizona (collective, the “Gilbert and Chandler Facilities”). Upon the closing of the acquisition, the Company assumed the seller’s interest, as lessor, in two existing leases and entered into three new leases, as lessor, at the Gilbert and Chandler Facilities. The Gilbert and Chandler Leases have a weighted average remaining lease term of 10.5 years, exclusive of tenant renewal options. IRF Portfolio On April 15, 2019, the Company purchased four in-patient rehabilitation facilities located in Las Vegas, Nevada; Surprise, Arizona; Oklahoma City, Oklahoma and Mishawaka, Indiana (collectively, the “IRF Portfolio”) for a total purchase price of approximately $94.6 million. Upon the closing of the acquisition, the Company assumed the sellers’ interest, as lessor, in four existing leases at the properties (collectively, the “IRF Portfolio Leases”) with (i) Encompass Health (Las Vegas, Nevada facility); (ii) a joint venture between Cobalt Rehabilitation and Tenet Healthcare (the Surprise, Arizona facility); (iii) a joint venture between Mercy Health and Kindred Healthcare (the Oklahoma City, Oklahoma facility); and (iv) St. Joseph’s Health System (the Mishawaka, Indiana facility). The IRF Portfolio leases have a weighted average remaining lease term of approximately 8.3 years, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Oklahoma Las Vegas Surprise Northwest Mishawaka Land and site improvements $ 2,723 $ 1,966 $ 2,507 $ 1,998 Building and tenant improvements 17,482 22,856 22,545 11,882 In-place leases 1,778 1,845 1,890 1,465 Above-market lease intangibles — 938 367 236 Leasing costs 519 1,077 898 522 Below-market lease intangibles (863) — — — Total purchase price $ 21,639 $ 28,682 $ 28,207 $ 16,103 San Marcos Facility On July 12, 2019, the Company purchased a medical office building located in San Marcos, California (the “San Marcos Facility”), for a purchase price of $12.0 million. Upon closing, the Company assumed the existing lease of the San Marcos Facility with California Cancer Associates for Research and Excellence, Inc., as tenant. The lease has eight years remaining in the initial term, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 2,448 Building and tenant improvements 7,338 In-place leases 698 Above-market lease intangibles 1,101 Leasing costs 389 Total purchase price $ 11,974 Lansing Facilities On August 1, 2019, the Company purchased the following real property and buildings thereon located in Lansing, Michigan for a total purchase price of $11.1 million: (i) 3390 East Jolly Road; (ii) 3955 Patient Care Drive; and (iii) 3400 East Jolly Road (“collectively, the “Lansing Facilities”). Upon closing, the Company assumed sellers’ interest, as lessor, in four existing leases and entered into two new leases at the Lansing Facilities (the “Lansing Leases”). The Lansing Leases have a weighted-average remaining term of 8.5 years, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 1,387 Building and tenant improvements 8,348 In-place leases 953 Above-market lease intangibles 130 Leasing costs 550 Below-market lease intangibles (248) Total purchase price $ 11,120 Bannockburn Facility On August 5, 2019, the Company purchased an office building located in Bannockburn, Illinois (the “Bannockburn Facility”), for a purchase price of $6.6 million. Upon closing, the Company assumed seller’s interest, as lessor, in 14 existing leases at the Bannockburn Facility (the “Bannockburn Leases”). The Bannockburn Leases have a weighted-average remaining term of 6.3 years, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 858 Building and tenant improvements 4,506 In-place leases 763 Above-market lease intangibles 240 Leasing costs 322 Below-market lease intangibles (138) Total purchase price $ 6,551 Aurora Facility On August 6, 2019, the Company purchased a medical office building located in Aurora, Illinois (the “Aurora Facility”), for a purchase price of $12.6 million. Upon closing, the Company assumed the existing lease of the Aurora Facility with Dreyer Clinic Inc., as tenant (the “Dreyer Lease”). The Dreyer Lease has approximately six years remaining in the initial term, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 1,829 Building and tenant improvements 8,049 In-place leases 1,417 Above-market lease intangibles 861 Leasing costs 401 Total purchase price $ 12,557 Livonia Facility On August 14, 2019, the Company purchased a medical office building located in Livonia, Michigan (the “Livonia Facility”) for a purchase price of $10.4 million. Upon closing, the Company assumed 10 existing leases at the Livonia Facility (the “Livonia Leases”). The Livonia Leases have a weighted-average remaining term of 3.2 years, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 1,181 Building and tenant improvements 8,071 In-place leases 1,252 Above-market lease intangibles 53 Leasing costs 35 Below-market lease intangibles (236) Total purchase price $ 10,356 Gilbert Facility On August 23, 2019, the Company purchased certain condominium units within two medical office buildings located in Gilbert, Arizona (the “Gilbert Facility”) for a total purchase price of $5.6 million. Upon closing, the Company leased the Gilbert Facility to Covenant Surgical Partners, Inc., a Delaware corporation (the “Covenant Lease”). The Covenant Lease has approximately ten (10) years remaining in the initial term, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 2,470 Building and tenant improvements 2,389 In-place leases 121 Above-market lease intangibles 300 Leasing costs 312 Total purchase price $ 5,592 Morgantown Facility On September 26, 2019, the Company purchased a parcel of land and an office building that is being constructed thereon, located in Morgantown, West Virginia (the “Morgantown Facility”) for a total purchase price of $8.0 million. Upon closing, the Company assumed the existing lease of the Morgantown Facility with Urgent Care MSO, LLC, as tenant (the “Urgent Care Lease”). The Urgent Care Lease has approximately ten years remaining in the initial term, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 1,256 Building and tenant improvements 5,792 In-place leases 457 Leasing costs 445 Total purchase price $ 7,950 Summary of Properties Acquired During the Nine Months Ended September 30, 2018 During the nine months ended September 30, 2018, the Company completed eight acquisitions. For all eight acquisitions, substantially all of the fair value of the acquisitions was concentrated in a single identifiable asset or group of similar identifiable assets and, therefore, all of the acquisitions represent asset acquisitions under the guidance provided by ASU 2017-01. Accordingly, transaction costs for these acquisitions were capitalized. A rollforward of the gross investment in land, building and improvements as of September 30, 2018, resulting from these acquisitions is as follows: Site & Tenant Acquired Lease Gross Investment in Land Building Improvements Intangibles Real Estate Balances as of January 1, 2018 $ 42,701 $ 384,338 $ 12,818 $ 31,650 $ 471,507 Facility Acquired – Date Acquired: Moline / Silvis – 1/24/18 - 4,895 1,216 989 7,100 Freemont – 2/9/18 162 8,335 — — 8,497 Gainesville – 2/23/18 625 9,885 — — 10,510 Dallas – 3/1/18 6,272 17,012 — — 23,284 Orlando – 3/22/18 2,543 11,720 756 1,395 16,414 Belpre – 4/19/18 3,025 50,526 3,966 7,166 64,683 McAllen – 7/3/18 1,099 4,296 5,395 Derby – 8/3/18 412 2,496 243 453 3,604 Tenant improvements (1) — — 2,043 — 2,043 Total Additions : 14,138 109,165 8,224 10,003 141,530 Balances as of September 30, 2018 $ 56,839 $ 493,503 $ 21,042 $ 41,653 $ 613,037 (1) Represents tenant improvements that were completed and placed in service during the three months ended September 30, 2018 related to the Silvis and Sherman facilities that were acquired in January 2018 and June 2017, respectively. These amounts were recorded as construction-in-process within the “Other Assets” line item in the Company’s Consolidated Balance Sheet as of September 30, 2018, and reclassified to investment in real estate once completed. The following is a summary of the acquisitions completed during the nine months ended September 30, 2018. Moline / Silvis Facilities Moline Facility - On January 24, 2018, the Company purchased a medical office building located in Moline, Illinois, which included the seller’s interest, as ground lessee, in an existing ground lease. The ground lease has approximately 10 years remaining in the initial term, with 12 consecutive five-year renewal options. Upon the closing of this acquisition, the Company assumed two subleases: one sublease with Fresenius Medical Care Quad Cities, LLC (“Fresenius”) with approximately 13 years remaining in the initial term, exclusive of tenant renewal options; and one sublease with Quad Cities Nephrology Associates, P.L.C. with approximately 15 years remaining in the initial term, exclusive of tenant renewal options. Silvis Facility - On January 24, 2018, the Company purchased a medical office building located in Silvis, Illinois from the same seller as the Moline facility, which included the seller’s interest, as ground lessee, in an existing ground lease. The ground lease has approximately 67 years remaining in the initial term, with no renewal options. Upon the closing of this acquisition, the Company assumed one sublease with Fresenius with approximately 13 years remaining in the initial term, exclusive of tenant renewal options. The aggregate purchase price for the Moline/Silvis facilities was $6.9 million. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed for this acquisition: Site improvements $ 249 Building and tenant improvements 5,862 In-place leases 343 Above market ground lease intangibles 219 Leasing costs 427 Below market lease intangibles (229) Total purchase price $ 6,871 Fremont Facility - On February 9, 2018, the Company purchased a medical office building located in Fremont, Ohio for a purchase price of approximately $8.5 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with Northern Ohio Medical Specialists, LLC (NOMS), exclusive of tenant renewal options. Gainesville Facility - On February 23, 2018, the Company purchased a medical office building and ambulatory surgery center located in Gainesville, Georgia for a purchase price of approximately $10.5 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with SCP Eye Care Services, LLC, exclusive of tenant renewal options. Dallas Facility - On March 1, 2018, the Company purchased a hospital, a three-story parking garage, and land all located in Dallas, Texas for an aggregate purchase price of $23.3 million. In addition to the hospital and the parking garage, the land underlays two medical office buildings that are not owned by the Company, each of which is ground leased to the hospital. Upon the closing of this acquisition, the Company entered into two leases with Pipeline East Dallas, LLC, with one lease relating to the hospital and the other lease relating to the underlying land and parking garage. Orlando Facilities - On March 22, 2018, the Company purchased five medical office buildings from five affiliated sellers for an aggregate purchase price of $16.4 million. Upon the closing of this acquisition, the Company assumed five existing leases with Orlando Health, Inc. (the “Orlando Leases”) The Orlando Leases have a weighted average remaining term of 4.5 years, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,075 Building and tenant improvements 11,944 In-place leases 808 Above market lease intangibles 229 Leasing costs 358 Below market lease intangibles (10) Total purchase price $ 16,404 Belpre Portfolio - On April 19, 2018, the Company purchased a portfolio of four medical office buildings and a right of first refusal to purchase a fifth, yet to be built, medical office building on the same campus, for an aggregate purchase price of $64.1 million. Upon the closing of the acquisition the Company assumed the existing leases with Marietta Memorial Hospital, a subsidiary of Memorial Health System and such leases had a weighted average remaining lease term of approximately 11.35 years, exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,997 Building and tenant improvements 53,520 In-place leases 2,660 Above market lease intangibles 2,527 Leasing costs 1,979 Below market lease intangibles (632) Total purchase price $ 64,051 McAllen Facility - On July 3, 2018, the Company purchased a medical office building (and adjacent condominium) located in McAllen, Texas for a purchase price of $5.4 million. Upon the closing of this acquisition, the Company entered into a new 11-year lease with Valley Ear, Nose, and Throat Specialists, PA, exclusive of tenant renewal options. Derby Facility - On August 3, 2018, the Company purchased a medical office building located in Derby, Kansas for a purchase price of $3.6 million. Upon the closing of this acquisition, the Company assumed the existing lease with Rock Surgery Center, LLC. The lease has approximately nine years remaining in its initial term, exclusive of a tenant renewal option. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 566 Building and tenant improvements 2,585 In-place leases 299 Above market lease intangibles Leasing costs 154 Below market lease intangibles (23) Total purchase price $ 3,581 Intangible Assets and Liabilities The following is a summary of the carrying amount of intangible assets and liabilities as of the dates presented: As of September 30, 2019 Accumulated Cost Amortization Net Assets In-place leases $ 34,697 $ (6,599) $ 28,098 Above market leases 12,236 (1,991) 10,245 Leasing costs 18,565 (2,899) 15,666 $ 65,498 $ (11,489) $ 54,009 Liabilities Below market leases $ 3,855 $ (568) $ 3,287 As of December 31, 2018 Accumulated Cost Amortization Net Assets In-place leases $ 21,753 $ (4,037) $ 17,716 Above market ground lease 707 (28) 679 Above market leases 8,009 (1,096) 6,913 Leasing costs 12,683 (1,703) 10,980 $ 43,152 $ (6,864) $ 36,288 Liability Below market leases $ 2,336 $ (308) $ 2,028 Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Amortization expense related to in-place leases $ 1,033 $ 647 $ 2,562 $ 1,797 Amortization expense related to leasing costs $ 467 $ 307 $ 1,195 $ 848 Decrease in rental revenue related to above market leases $ 343 $ 240 $ 895 $ 620 Increase in rental revenue related to below market leases $ 114 $ 56 $ 261 $ 152 The following is a summary of the acquired lease intangible amortization: As of September 30, 2019, scheduled future aggregate net amortization of the acquired lease intangible assets and liabilities for each fiscal year ended December 31 is listed below: Net Decrease Net Increase in Revenue in Expenses 2019 (three months remaining) $ (246) $ 1,655 2020 (986) 6,601 2021 (988) 5,987 2022 (998) 5,620 2023 (1,024) 5,004 Thereafter (2,716) 18,897 Total $ (6,958) $ 43,764 As of September 30, 2019, the weighted average amortization periods for asset lease intangibles and liability lease intangibles were 6.42 years and 6.41 years, respectively.

Credit Facility, Notes Payable

Credit Facility, Notes Payable and Derivative Instruments	9 Months Ended
	Sep. 30, 2019
Credit Facility, Notes Payable and Derivative Instruments
Credit Facility, Notes Payable and Derivative Instruments	Note 4 –Credit Facility, Notes Payable and Derivative Instruments Credit Facility The Company, the Operating Partnership, as borrower, and certain of its subsidiaries (such subsidiaries, the “Subsidiary Guarantors”) are parties to a syndicated credit facility with BMO Harris Bank N.A. (“BMO”), as administrative agent (the “Credit Facility”). Amounts outstanding under the credit facility bear interest at a floating rate that is based on LIBOR, plus a specified margin based on the Company’s leverage. On September 30, 2019, the Company entered into an amendment to the Credit Facility that, among other things, (i) increased the borrowings under the term-loan component (the “Term Loan”) from $175 million to $300 million, representing the exercise of the remaining $75 million accordion feature and a re-allocation of $50 million from the revolver component (the “Revolver”) to the Term Loan and (ii) added a new $150 million accordion feature. Upon execution of the first amendment to the Company’s Credit Facility, the Credit Facility consisted of a $200 million capacity Revolver, a $300 million Term Loan and a $150 million accordion. The term of the Company’s Credit Facility expires in August 2022, subject to a one-year extension option. The amendment also amends the restricted payments financial covenant by deferring implementation of the 95% AFFO payout limitation contained in Section 8.24(a) of the Credit Facility from the fourth quarter of 2019 to the fourth quarter of 2020 and provides a mechanism for determining an alternative benchmark rate to LIBOR. The Subsidiary Guarantors and the Company are guarantors of the obligations under the Credit Facility. The amount available to borrow from time to time under the Credit Facility is limited according to a quarterly borrowing base valuation of certain properties owned by the Subsidiary Guarantors. The Operating Partnership is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales. The Operating Partnership must also maintain (i) a maximum consolidated leverage ratio as of the end of each fiscal quarter of less than (y) 0.65:1.00 for each fiscal quarter ending prior to October 1, 2019 and (z) thereafter, 0.60:1.00, (ii) a minimum fixed charge coverage ratio of 1.50:1.00, (iii) a minimum net worth of $203,795 plus 75% of all net proceeds raised through equity offerings subsequent to March 31, 2018, and (iv) a ratio of total secured recourse debt to total asset value of not greater than 0.10:1.00. The Company was in compliance with the Credit Facility covenants as of September 30, 2019. The Company has entered into interest rate swaps to hedge its interest rate risk on the Term Loan. For additional information related to the interest rate swaps, see the “Derivative Instruments - Interest Rate Swaps” and “Subsequent Events” sections herein. During the nine months ended September 30, 2019, the Company borrowed $164,450 under the Credit Facility and repaid $77,500, for a net amount borrowed of $86,950. During the nine months ended September 30, 2018 the Company borrowed $142,900 under the Credit Facility and repaid $10,400, for a net amount borrowed of $132,500. Interest expense incurred on the Credit Facility was $3,716 and $10,268 for the three and nine months ended September 30, 2019 , respectively, and $3,211 and $7,872 for the three and nine months ended September 30, 2018, respectively. As of September 30, 2019 and December 31, 2018, the Company had the following outstanding borrowings under the Credit Facility: September 30, 2019 December 31, 2018 Revolver $ 67,225 $ 180,275 Term Loan 300,000 100,000 Less: Unamortized deferred financing costs (3,983) (3,922) Credit Facility, net $ 363,242 $ 276,353 Costs incurred related to the Credit Facility, net of accumulated amortization, are netted against the Company’s “Credit Facility, net of unamortized discount” balance in the accompanying Condensed Consolidated Balance Sheets. The Company paid $924 and $2,750 during the nine months ended September 30, 2019 and 2018, respectively, related to modifications to the Credit Facility and borrowing base additions. Amortization expense incurred was $303 and $863 for the three and nine months ended September 30, 2019, respectively, and $455 and $1,373 for the three and nine months ended September 30, 2018, respectively, and is included in the “Interest Expense” line item in the accompanying Condensed Consolidated Statements of Operations. In July 2017, the Financial Conduct Authority (the “FCA”) that regulates LIBOR announced its intention to stop compelling banks to submit rates for the calculation of LIBOR after 2021. As a result, the Federal Reserve Board and the Federal Reserve Bank of New York organized the Alternative Reference Rates Committee ("ARRC") which identified the Secured Overnight Financing Rate ("SOFR") as its preferred alternative to USD-LIBOR in derivatives and other financial contracts. The Credit Facility provides that, on or about the LIBOR cessation date (subject to an early opt-in election), LIBOR shall be replaced as a benchmark rate in the Credit Facility with a new benchmark rate to be agreed upon by the Company and BMO, with such adjustments to cause the new benchmark rate to be economically equivalent to LIBOR. The Company is not able to predict when LIBOR will cease to be available or when there will be sufficient liquidity in the SOFR markets. The Company has interest rate swap agreements that are indexed to LIBOR and is monitoring and evaluating the related risks. These risks arise in connection with transitioning contracts to a new alternative rate, including any resulting value transfer that may occur. The value of loans, securities, or derivative instruments tied to LIBOR could also be impacted if LIBOR is limited or discontinued. For some instruments, the method of transitioning to an alternative rate may be challenging, as they may require negotiation with the respective counterparty. If a contract is not transitioned to an alternative rate and LIBOR is discontinued, the impact on our interest rate swap agreements is likely to vary by agreement. If LIBOR is discontinued or if the methods of calculating LIBOR change from their current form, interest rates on our current or future indebtedness may be adversely affected. While we expect LIBOR to be available in substantially its current form until the end of 2021, it is possible that LIBOR will become unavailable prior to that point. This could result, for example, if sufficient banks decline to make submissions to the LIBOR administrator. In that case, the risks associated with the transition to an alternative reference rate will be accelerated and magnified. Notes Payable, Net of Discount The Company’s notes payable, net, includes two loans: (1) the Cantor Loan and (2) the West Mifflin Note, described in detail below. The following table sets forth the aggregate balances of these loans as of September 30, 2019 and December 31, 2018. September 30, 2019 December 31, 2018 Notes payable, gross $ 39,475 $ 39,475 Less: Unamortized debt discount (701) (799) Cumulative principal repayments (123) (22) Notes payable, net $ 38,651 $ 38,654 Amortization expense incurred related to the debt discount was $32 and $98 for the three and nine months ended September 30, 2019, respectively, and $33 and $98 for the three and nine months ended September 30, 2018, respectively, and is included in the “Interest Expense” line item in the accompanying Condensed Consolidated Statements of Operations. Cantor Loan On March 31, 2016, through certain of its wholly-owned subsidiaries, the Company entered into a $32,097 portfolio commercial mortgage-backed securities loan (the “Cantor Loan”) with Cantor Commercial Real Estate Lending, LP (“CCRE”). The subsidiaries are GMR Melbourne, LLC, GMR Westland, LLC, GMR Memphis, LLC, and GMR Plano, LLC (the “GMR Loan Subsidiaries”). The Cantor Loan has cross-default and cross-collateral terms. The Cantor Loan has a maturity date of April 6, 2026 and accrues annual interest at 5.22%. The first five years of the term require interest-only payments and thereafter payments will include interest and principal, amortized over a 30‑year schedule. Prepayment can only occur within four months prior to the maturity date, except that the Cantor Loan can be fully or partially defeased upon payment of amounts due under the Cantor Loan and payment of a defeasance amount that is sufficient to purchase U.S. government securities equal to the scheduled payments of principal, interest, fees, and any other amounts due related to a full or partial defeasance under the Cantor Loan. The Company secured the payment of the Cantor Loan with the assets, including property, facilities, and rents, held by the GMR Loan Subsidiaries and has agreed to guarantee certain customary recourse obligations, including findings of fraud, gross negligence, or breach of environmental covenants by the GMR Loan Subsidiaries. The GMR Loan Subsidiaries are required to maintain an aggregate monthly debt service coverage ratio of 1.35:1.00 for all of the collateral properties. The note balance as of September 30, 2019 and December 31, 2018 was $32,097. Interest expense incurred on this note was $429 and $1,271 for the three and nine months ended September 30, 2019, respectively, and $428 and $1,271 for the three and nine months ended September 30, 2018, respectively. As of September 30, 2019, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2019 $ — 2020 — 2021 282 2022 447 2023 471 Thereafter 30,897 Total $ 32,097 West Mifflin Note On September 25, 2015, the Company, through its wholly-owned subsidiary GMR Pittsburgh LLC, as borrower, entered into a Term Loan and Security Agreement with Capital One to borrow $7,378. The note bears interest at 3.72% per annum and all unpaid interest and principal is due on September 25, 2020. Interest is paid in arrears and interest payments began on November 1, 2015 and have continued on the first day of each calendar month thereafter. Principal payments began on November 1, 2018 and have continued on the first day of each calendar month thereafter based on an amortization schedule with the remaining principal balance due on the maturity date. The Company, at its option, may prepay the note at any time in whole (but not in part) with advanced written notice. The West Mifflin facility serves as collateral for the note. The note requires a quarterly fixed charge coverage ratio of at least 1:1, a quarterly minimum debt yield of 0.09:1.00, and annualized Operator EBITDAR (as defined in the note) measured on a quarterly basis of not less than $6,000. The Operators are Associates in Ophthalmology, Ltd. and Associates Surgery Centers, LLC. The Company made principal payments of $101 during the nine months ended September 30, 2019. The note balance as of September 30, 2019 and December 31, 2018 was $7,255 and $7,356, respectively. Interest expense incurred on this note was $69 and $207 for the three and nine months ended September 30, 2019, respectively, and $72 and $211 for the three and nine months ended September 30, 2018, respectively. As of September 30, 2019, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2019 (three months remaining) $ 35 2020 7,220 Total $ 7,255 Derivative Instruments - Interest Rate Swaps As of September 30, 2019, the Company had three interest rate swaps that are used to manage the interest rate risk and fix the LIBOR component of certain of its floating rate debt as follows: (i) on August 7, 2018 the Company executed an interest rate swap with BMO that was designated as a cash flow hedge on the Term Loan, with a notional amount of $100 million, a fixed interest rate of 2.88%, and a maturity date of August 8, 2023; and (ii) on November 16, 2018 the Company executed separate interest rate swaps with SunTrust Bank (“SunTrust”) and Citizens Bank of Pennsylvania (“Citizens”) that were each designated as cash flow hedges. The swap with SunTrust has a notional amount of $40 million and the swap with Citizens has a notional amount of $30 million and both have a fixed interest rate of 2.93% and a maturity date of August 7, 2024. Additionally, as discussed in Note 11 - "Subsequent Events," on October 3, 2019, the Company executed two additional interest rate swaps with a combined notional amount of $130 million. In accordance with the provisions of ASC Topic 815, the Company records the swaps either as an asset or a liability measured at its fair value at each reporting period. When hedge accounting is applied, the change in the fair value of derivatives designated and that qualify as cash flow hedges is (i) recorded in accumulated other comprehensive loss in the equity section of the Company’s Condensed Consolidated Balance Sheets and (ii) subsequently reclassified into earnings as interest expense for the period that the hedged forecasted transactions affect earnings. If specific hedge accounting criteria are not met, changes in the Company’s derivative instruments’ fair value are recognized currently as an adjustment to net income. The Company’s interest rate swaps are not traded on an exchange. The Company’s interest rate swaps are recorded at fair value based on a variety of observable inputs including contractual terms, interest rate curves, yield curves, measure of volatility, and correlations of such inputs. The Company measures its derivatives at fair value on a recurring basis based on the expected size of future cash flows on a discounted basis and incorporating a measure of non-performance risk. The fair values are based on Level 2 inputs within the framework of ASC Topic 820, “Fair Value Measurement.” The Company considers its own credit risk, as well as the credit risk of its counterparty, when evaluating the fair value of its derivative instruments. The fair value of the Company’s interest rate swaps was a liability of $10,399 and $3,487 as of September 30, 2019 and December 31, 2018, respectively. These amounts are included in the “Derivative Liability” line item on the Company’s Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018. The table below details the components of the loss presented on the accompanying Condensed Consolidated Statements of Comprehensive (Loss) Income recognized on the Company’s interest rate swaps designated as cash flow hedges for the three and nine months ended September 30, 2019 and 2018: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Amount of loss recognized in other comprehensive loss $ 1,603 $ 122 $ 7,559 $ 122 Amount of loss reclassified from accumulated other comprehensive loss into interest expense (300) (13) (684) (13) Total change in accumulated other comprehensive loss $ 1,303 $ 109 $ 6,875 $ 109 During the next twelve months, the Company estimates that an additional $2,193 will be reclassified as an increase to interest expense. Additionally, during the three and nine months ended September 30, 2019, the Company recorded total interest expense in its Condensed Consolidated Statements of Operations of $4,549 and $12,707. Weighted-Average Interest Rate and Term The weighted average interest rate and term of the Company’s debt was 4.19% and 3.85 years at September 30, 2019, compared to 4.64% and 4.24 years as of December 31, 2018.

Equity

Equity	9 Months Ended
	Sep. 30, 2019
Equity
Equity	Note 5 – Equity Preferred Stock The Company’s charter authorizes the issuance of 10,000 shares of preferred stock, par value $0.001 per share. As of September 30, 2019 and December 31, 2018, there were 3,105 shares of Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”), issued and outstanding. The Series A Preferred Stock has a liquidation preference of $25 per share. Preferred stock dividend activity for the nine months ended September 30, 2019 is summarized in the following table: Applicable Quarterly Dividends Date Announced Record Date Quarter Payment Date Dividend per Share December 13, 2018 January 15, 2019 Q4 2018 January 31, 2019 $ 1,455 $ 0.46875 March 6, 2019 April 15, 2019 Q1 2019 April 30, 2019 $ 1,455 $ 0.46875 June 14, 2019 July 15, 2019 Q2 2019 July 31, 2019 $ 1,455 $ 0.46875 September 13, 2019 October 15, 2019 Q3 2019 October 31, 2019 $ (1) $ (1) Two months of this amount, equal to $970, was accrued at September 30, 2019. The holders of the Series A Preferred Stock are entitled to receive dividend payments only when, as and if declared by the Board (or a duly authorized committee of the Board). Dividends will accrue or be payable in cash from the original issue date, on a cumulative basis, quarterly in arrears on each dividend payment date at a fixed rate per annum equal to 7.50% of the liquidation preference of $25.00 per share (equivalent to $1.875 per share on an annual basis). Dividends on the Series A Preferred Stock will be cumulative and will accrue whether or not (i) funds are legally available for the payment of those dividends, (ii) the Company has earnings or (iii) those dividends are declared by the Board. The quarterly dividend payment dates on the Series A Preferred Stock are January 31, April 30, July 31 and October 31 of each year. During the nine month periods ended September 30, 2019 and 2018, the Company paid preferred dividends of $4,365 and $4,366, respectively. The Company may, at its option, redeem the Serial A Preferred Stock for cash in whole or in part, from time-to-time, on or after September 15, 2022 at a cash redemption price of $25.00 per share, plus any accrued and unpaid dividends up to, but not including, the date of redemption. Common Stock The Company has 500,000 authorized shares of common stock, $0.001 par value. As of September 30, 2019 and December 31, 2018, there were 36,290 and 25,944 outstanding shares of common stock, respectively. On March 18, 2019, the Company closed an underwritten public offering of its common stock and on March 25, 2019 the Company closed on part of the related over-allotment option granted to the underwriters, resulting in $75,191 in net proceeds. On August 17, 2018, the Company, its Advisor, and the Operating Partnership entered into a Sales Agreement, as amended on June 21, 2019, with a number of financial institutions, pursuant to which the Company may offer and sell, from time to time, up to $50 million of its common stock (the “ATM Program”). During the nine months ended September 30, 2019, pursuant to the ATM Program, the Company sold and issued 2,051 shares of its common stock at an average price of $10.73 per share, receiving net proceeds of $21,608. Common stock dividend activity for the nine months ended September 30, 2019 is summarized in the following table: Applicable Dividend Dividends Date Announced Record Date Quarter Payment Date Amount (1) per Share December 13, 2018 December 26, 2018 Q4 2018 January 10, 2019 $ 5,695 $ 0.20 March 6, 2019 March 26, 2019 Q1 2019 April 10, 2019 $ 7,688 $ 0.20 June 14, 2019 June 26, 2019 Q2 2019 July 11, 2019 $ 7,699 $ 0.20 September 13, 2019 September 25, 2019 Q3 2019 October 10, 2019 $ $ 0.20 (1) Includes distributions on LTIP Units and OP Units. During the nine months ended September 30, 2019 and 2018, the Company paid total dividends on its common stock, LTIP Units and OP Units in the aggregate amount of $21,167 and $14,075, respectively. As of September 30, 2019 and December 31, 2018, the Company had an accrued dividend balance of $496 and $316 for dividends payable on the aggregate annual and long-term LTIP Units that are subject to retroactive receipt of dividends on the amount of LTIP Units ultimately earned. During the nine months ended September 30, 2019, $265 of dividends were accrued and $85 of dividends were paid related to these units. During the nine months ended September 30, 2018, $180 of dividends were accrued and $46 of dividends were paid. The amount of the dividends paid to the Company’s stockholders is determined by the Company’s Board and is dependent on a number of factors, including funds available for payment of dividends, the Company’s financial condition and capital expenditure requirements except that, in accordance with the Company’s organizational documents and Maryland law, the Company may not make dividend distributions that would: (i) cause it to be unable to pay its debts as they become due in the usual course of business; (ii) cause its total assets to be less than the sum of its total liabilities plus senior liquidation preferences; or (iii) jeopardize its ability to maintain its qualification as a REIT. OP Units OP Units are limited partnership interests in the Company's Operating Partnership. OP Units are redeemable by the holder for cash or, at the Company's option, an equivalent number of shares of the Company's common stock. During the nine months ended September 30, 2019, the Company issued an aggregate of 49 OP Units with a value of $506 in connection with a facility acquisition. Additionally, during the nine months ended September 30, 2019, two OP Unit holders redeemed an aggregate of 51 OP Units that were issued during 2017 in connection with a facility acquisition. The Company redeemed such OP Units for shares of its common stock with a value of $519. During the year ended December 31, 2018, the Company issued an aggregate of 1,899 OP Units with a value of $16,363 in connection with three facility acquisitions. As of September 30, 2019 and December 31, 2018, there were 3,143 and 3,145 OP Units issued and outstanding, respectively, with an aggregate value of $27,881 and $27,894, respectively. The OP Unit value is based on the Company’s closing share price on the date of the respective transaction and is included as a component of noncontrolling interest equity in the Company’s Condensed Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions
Related Party Transactions	Note 6 – Related Party Transactions Management Agreement Upon completion of the Company’s initial public offering on July 1, 2016, the Company and the Advisor entered into an amended and restated management agreement (the “Management Agreement”). Certain material terms of the Management Agreement are summarized in the section titled “ Business — Our Advisor and our Management Agreement ,” contained in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2018 filed with the SEC on March 11, 2019. Management Fees and Accrued Management Fees The Company’s management fee to the Advisor is calculated in accordance with the terms of the Management Agreement, which requires an annual base management fee equal to 1.5% of our stockholders’ equity (as defined in the Management Agreement). For the three and nine months ended September 30, 2019, management fees of $1,621 and $4,539, respectively, were incurred and expensed by the Company. For the three and nine months ended September 30, 2018, management fees of $1,104 and $3,280, respectively , were incurred and expensed by the Company. Accrued management fees due to the Advisor were $1,622 and $1,143 as of September 30, 2019 and December 31, 2018, respectively. No incentive management fee was incurred by the Company during the three and nine months ended September 30, 2019 or 2018. Allocated General and Administrative Expenses Effective May 8, 2017, the Company and the Advisor entered into an agreement pursuant to which, for a period of one year commencing on May 8, 2017, the Company agreed to reimburse the Advisor for $125 of the annual salary of the General Counsel and Secretary of the Company for so long as he continues to be primarily dedicated to the Company in his capacity as its General Counsel and Secretary. This agreement expired in May 2018 and was not renewed. In the future, the Company may receive additional allocations of general and administrative expenses from the Advisor that are either clearly applicable to or were reasonably allocated to the operations of the Company. There were no allocated general and administrative expenses from the Advisor for the three and nine months ended September 30, 2019. Other than via the terms of the reimbursement agreement noted above, there were no allocated general and administrative expenses from the Advisor for the three and nine months ended September 30, 2018. Related Party Balances A rollforward of the due from related parties and due to related party balance, net, as of September 30, 2019 is as follows: Due From Related Parties Due to Related Party,Net Other Funds for Mgmt.Fees Funds due Due to Various due to from Related Purposes Advisor Advisor Party, net Balance as of January 1, 2019 $ 61 $ (1,143) 52 $ (1,091) Management fee expense incurred — (4,539) — (4,539) Management fees paid to Advisor — 4,060 — 4,060 Loans to Advisor — — (14) (14) Loans to other related parties 14 — — — Balance as of September 30, 2019 $ 75 $ (1,622) 38 $ (1,584)

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2019
Stock-Based Compensation
Stock-Based Compensation	Note 7 – Stock-Based Compensation 2016 Equity Incentive Plan The 2016 Equity Incentive Plan, as amended (the “Plan”) is intended to assist the Company and its affiliates in recruiting and retaining employees of the Manager, members of the Board, executive officers of the Company, and individuals who provide services to those entities or affiliates of those entities. The Plan is intended to permit the grant of both qualifying and non-qualified options and the grant of stock appreciation rights, restricted stock, unrestricted stock, awards of restricted stock units, performance awards and other equity-based awards (including LTIP Units) for up to an aggregate of 2,232 shares of common stock, subject to increase under certain provisions of the Plan. On May 29, 2019, the Company's stockholders approved an amendment to the Plan to increase the number of authorized shares available for issuance under the Plan by 1,000 shares from 1,232 to 2,232. Based on the grants outstanding as of September 30, 2019, there are 1,020 units that remain available to be granted under the Plan. Units subject to awards under the Plan that are forfeited, cancelled, lapsed, settled in cash or otherwise expired (excluding shares withheld to satisfy exercise prices or tax withholding obligations) are available for grant. Time-Based Grants The time-based vesting LTIP unit activity under the Plan during the nine months ended September 30, 2019 was as follows: LTIP Units outstanding as of December 31, 2018 588 LTIP Units earned and granted via the 2018 performance program – Annual Awards (1) 108 LTIP Units granted on a discretionary basis related to the Annual Awards (2) 28 LTIP Units granted as 2019 long-term time based awards (3) 54 LTIP Units granted to independent directors of the Board (4) 22 LTIP Units – other grant and forfeitures, net (5) (9) LTIP Units outstanding as of September 30, 2019 791 (1) The 108 LTIP Units represents earned and granted units from the previously disclosed 2018 annual awards (the “Annual Awards”). On March 5, 2019 the Compensation Committee of the Board (the “Compensation Committee”) determined the extent to which the Company achieved the performance goals related to the 2018 Annual Awards and determined the number of LTIP Units that each grantee was entitled to receive. These grants vested 50% on March 5, 2019, the determination date, and 50% vest on March 5, 2020. (2) The 28 LTIP Units represents a discretionary grant by the Board. These grants vested 50% on March 5, 2019, the grant date, and 50% vest on March 5, 2020. (3) The 54 LTIP Units represent grants approved by the Board on March 5, 2019 pursuant to the Company' 2019 Long-Term Incentive Plan. These grants are valued based on the Company’s share price at the date of grant of $10.07 and vest in equal one-third increments on each of March 5, 2020, March 5, 2021, and March 5, 2022. (4) The 22 LTIP Units represent a grant to the independent directors of the Board made on May 29, 2019, which vest on May 29, 2020. (5) The decrease of nine LTIP Units net represents 11 LTIP Units redeemed for the Company’s common stock with a value of $110 and one LTIP Unit that was forfeited, partially offset by three LTIP Units that were granted on March 15, 2019 related to a new hire. These three LTIP Units vest in equal one-third increments on each of March 15, 2020, March 15, 2021, and March 5, 2022. A detail of the vested and unvested LTIP units outstanding as of September 30, 2019 is as follows: Total vested units 483 Unvested units: Granted to employees of the Advisor 286 Granted to the Company’s independent directors 22 Total unvested units 308 LTIP Units outstanding as of September 30, 2019 791 Performance Based Awards For each of the past three years the Company’s Board has approved annual performance-based LTIP awards (“Annual Awards”) and long-term performance-based LTIP awards (“Long-Term Awards”) to the executive officers of the Company and other employees of the Advisor who perform services for the Company. As described in detail below the Annual Awards have one-year performance periods and the Long-Term Awards have three-year performance periods. In addition to meeting specified performance metrics, vesting in both the Annual Awards and the Long-Term Awards is subject to service requirements. A detail of the Annual Awards and Long-Term Awards under the 2017, 2018, and 2019 programs as of September 30, 2019 is as follows: 2017 Program 2018 Program 2019 Program Long-Term Annual Long-Term Annual Long-Term Total Net annual and long-term LTIP awards as of December 31, 2018 (at target) 96 161 110 — — 367 LTIP Unit target grants via the 2019 Performance Program – Annual Awards and Long-Term Awards (1) — — — 133 82 215 LTIP Units earned and granted via the 2018 Performance Program – Annual Awards (2) — (108) — — — (108) LTIP Units granted on a discretionary basis via the 2018 Performance Program – Annual Awards (2) — (28) — — — (28) LTIP Units not earned under the 2018 Performance Program – Annual Awards (3) — (25) — — — (25) Net annual and long-term LTIP awards as of September 30, 2019 (at target) 96 — 110 133 82 421 (1) These target Annual Awards and Long-Term Awards were approved by the Board on March 5, 2019. (2) These amounts represent grants from the 2018 program Annual Awards. Refer to the “Time-Based Grants” table above which presents these grants as earned and time-based. (3) On March 5, 2019 the Compensation Committee determined the extent to which the Company achieved the performance goals and concluded that these target awards were not achieved. The number of target LTIP Units comprising each 2019 program Annual Award target grant was based on the closing price of the Company’s common stock reported on the New York Stock Exchange (“NYSE”) on the date of grant. The number of target LTIP Units comprising each Long-Term Award target grant was based on the fair value of the Long-Term Awards as determined by an independent valuation consultant, in each case rounded to the nearest whole LTIP unit in order to eliminate fractional units. Annual Awards . The Annual Awards are subject to the terms and conditions of LTIP Annual Award Agreements (“LTIP Annual Award Agreements”) between the Company and each grantee. The Compensation Committee and Board established performance goals for fiscal year 2019, as set forth in Exhibit A to the 2019 LTIP Annual Award Agreements (the “Performance Goals”) that will be used to determine the number of LTIP Units earned by each grantee. As of September 30, 2019, management estimated that the Performance Goals would be met at a 100% level, and accordingly, applied 100% to the net target 2019 program Annual Awards to estimate the 2019 program Annual Awards expected to be earned at the end of the performance period. Cumulative stock-based compensation expense during the nine months ended September 30, 2019 reflects management’s estimate that 100% of these awards will be earned. As soon as reasonably practicable following the last day of the 2019 fiscal year, the Compensation Committee and Board will determine the extent to which the Company has achieved each of the Performance Goals (expressed as a percentage) and, based on such determination, will calculate the number of LTIP Units that each grantee is entitled to receive. Each grantee may earn up to 150% of the number of his/her target LTIP Units. Any 2019 Annual Award LTIP Units that are not earned will be forfeited and cancelled. Vesting. LTIP Units that are earned as of the end of the applicable performance period will be subject to vesting, subject to continued employment through each vesting date, in two installments as follows: 50% of the earned LTIP Units will become vested on the date in 2020 that the Board approves the number of LTIP Units to be awarded pursuant to the performance components set forth in the 2019 LTIP Annual Award Agreements and 50% of the earned LTIP Units become vested on the one year anniversary of the initial vesting date. Vesting may be accelerated under certain circumstances such as a “change-in-control” transaction or a “qualified termination” event. Distributions. Distributions equal to the dividends declared and paid by the Company will accrue during the applicable performance period on the maximum number of LTIP Units that the grantee could earn and will be paid with respect to all of the earned LTIP Units at the conclusion of the applicable performance period, in cash or by the issuance of additional LTIP Units at the discretion of the Compensation Committee. Long-Term Awards. The Long-Term Awards are subject to the terms and conditions of 2017, 2018 and 2019 LTIP Long-Term Award Agreements (collectively the “LTIP Long-Term Award Agreements”) between the Company and each grantee. The number of LTIP Units that each grantee is entitled to earn under the LTIP Long-Term Award Agreements will be determined following the conclusion of a three-year performance period based on the Company’s total stockholder return (“TSR”), which is determined based on a combination of appreciation in stock price and dividends paid during the performance period. Each grantee may earn up to 200% of the number of target LTIP Units covered by the grantee’s Long-Term Award. Any target LTIP Units that are not earned will be forfeited and cancelled. The number of LTIP Units earned under the Long-Term Awards will be determined as soon as reasonably practicable following the end of the applicable three-year performance period (2020, 2021, or 2022 depending on the program) based on the Company’s TSR on an absolute basis (as to 75% of the Long-Term Award) and relative to the SNL Healthcare REIT Index (as to 25% of the Long-Term Award). Vesting. LTIP Units that are earned as of the end of the applicable three year performance period will be subject to forfeiture restrictions that will lapse (“vesting”), subject to continued employment through each vesting date as follows; 50% of the earned LTIP Units will vest upon the third anniversary of the respective grant dates and the remaining 50% will vest on the fourth anniversary of the respective grant dates. Vesting may be accelerated under certain circumstances such as a “change-in-control” transaction or a “qualified termination” event. Distributions. Pursuant to the LTIP Long-Term Award Agreements, distributions equal to the dividends declared and paid by the Company will accrue during the applicable performance period on the maximum number of LTIP Units that the grantee could earn and will be paid with respect to all of the earned LTIP Units at the conclusion of the applicable performance period, in cash or by the issuance of additional LTIP Units at the discretion of the Compensation Committee. Stock-Based Compensation Expense In July 2018, the Company implemented the provisions of ASU 2018‑07, “Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018‑07”). This standard simplifies several aspects of the accounting for non-employee transactions by stipulating that the existing accounting guidance for share-based payments to employees (accounted for under ASC Topic 718, “Compensation-Stock Compensation”) will also apply to non-employee share-based transactions (accounted for under ASC Topic 505, “Equity”). Under the provisions of ASU 2018‑07, the Company’s prospective compensation expense for all unvested LTIP Units, Annual Awards, and Long-Term Awards is recognized using the adoption date fair value of the awards, with no remeasurement required. Compensation expense for future LTIP Unit grants, Annual Awards, and Long-Term Awards is based on the grant date fair value of the units/awards, with no subsequent remeasurement required. As the Long-Term Awards involve market-based performance conditions, the Company utilizes a Monte Carlo simulation to provide a grant date fair value for expense recognition. The Monte Carlo simulation is a generally accepted statistical technique used, in this instance, to simulate a range of possible future stock prices for the Company and the members of the SNL Healthcare REIT Index (the “Index”) over the Performance Periods. The purpose of this modeling is to use a probabilistic approach for estimating the fair value of the performance share award for purposes of accounting under ASC Topic 718. The assumptions used in the Monte Carlo simulation include beginning average stock price, valuation date stock price, expected volatilities, correlation coefficients, risk-free rate of interest, and expected dividend yield. The beginning average stock price is the beginning average stock price for the Company and each member of the Index for the five trading days leading up to the grant date of the Long-Term Award. The valuation date stock price is the closing stock price of the Company and each of the peer companies in the Index on the grant dates of the Long-Term Awards. The expected volatilities are modeled using the historical volatilities for the Company and the members of the Index. The correlation coefficients are calculated using the same data as the historical volatilities. The risk-free rate of interest is taken from the U.S. Treasury website and relates to the expected life of the remaining performance period on valuation or revaluation. Lastly, the dividend yield assumption is 0.0%, which is mathematically equivalent to reinvesting dividends in the issuing entity, which is part of the Company’s award agreement assumptions. Below are details regarding certain of the assumptions for the Long-Term Awards using Monte Carlo simulations: 2019 Long-Term 2018 Long-Term 2017 Long-Term Awards Awards Awards Share price $ 10.07 $ 8.86 $ 8.86 Target awards 82 110 96 Volatility 31.7 % 33.8 % 33.8% - 35.4% Risk-free rate 2.5 % 2.6 % 2.4% - 2.6% Dividend assumption reinvested reinvested reinvested Expected term in years 1.7 – 2.7 The Company incurred stock compensation expense of $868 and $2,493, for the three and nine months ended September 30, 2019 , respectively, and $741 and $1,978, for the three and nine months ended September 30,2018, respectively, related to the grants awarded under the Plan. Compensation expense is included within “General and Administrative” expense in the Company’s Condensed Consolidated Statements of Operations. As of September 30, 2019, total unamortized compensation expense related to these awards of approximately $3.5 million is expected to be recognized over a weighted average remaining period of 1.5 years.

Leases

Leases	9 Months Ended
	Sep. 30, 2019
Leases
Leases	Note 8 – Leases On January 1, 2019, the Company adopted ASC Topic 842, which supersedes Accounting Standards Codification Topic 840 “Leases” (“ASC Topic 840”). Information in this note with respect to the Company’s leases and lease-related costs as both lessee and lessor and lease-related receivables as lessor is presented under ASC Topic 842 as of and for the three and nine months ended September 30, 2019 and under ASC Topic 840 as of and for the year ended December 31, 2018. The Company adopted ASC Topic 842 using the modified retrospective approach whereby the cumulative effect of adoption was recognized on the adoption date and prior periods were not restated. There was no net cumulative effect adjustment to accumulated deficit as of January 1, 2019 as a result of this adoption. ASC Topic 842 sets out the principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The Company operates as both a lessor and a lessee. As a lessor, the Company is required under ASC Topic 842 to account for leases using an approach that is substantially similar to ASC Topic 840’s guidance for operating leases and other leases such as sales-type leases and direct financing leases. In addition, ASC Topic 842 requires lessors to capitalize and amortize only incremental direct leasing costs. As a lessee, the Company is required under the new standard to apply a dual approach, classifying leases, such as ground leases, as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase. This classification determines whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. ASC Topic 842 also requires lessees to record a right of use asset and a lease liability for all leases with a term of greater than a year regardless of their classification. The Company has also elected the practical expedient not to recognize right of use assets and lease liabilities for leases with a term of a year or less. On adoption of the standard, we elected the package of practical expedients provided for in ASC Topic 842, including: · No reassessment of whether any expired and existing contracts were or contained leases; · No reassessment of the lease classification for any expired and existing leases; and · No reassessment of initial direct costs for any existing leases. The package of practical expedients was made as a single election and was consistently applied to all existing leases as of January 1, 2019. We also elected the practical expedient provided to lessors in a subsequent amendment to ASC Topic 842 that removed the requirement to separate lease and nonlease components, provided certain conditions were met. Information as Lessor Under ASC Topic 842 (As of and for the three and nine months ended September 30, 2019) To generate positive cash flow, as a lessor, the Company leases its facilities to tenants in exchange for fixed monthly payments that cover rent, property taxes, insurance and certain cost recoveries, primarily common area maintenance (“CAM”). The Company’s leases were determined to be operating leases and have a portfolio average lease years remaining of approximately 10 years. Payments from the Company’s tenants for CAM are considered nonlease components that are separated from lease components and are generally accounted for in accordance with the revenue recognition standard. However, the Company qualified for and elected the practical expedient related to combining the components because the lease component is classified as an operating lease and the timing and pattern of transfer of CAM income, which is not the predominant component, is the same as the lease component. As such, consideration for CAM is accounted for as part of the overall consideration in the lease. Payments from customers for property taxes and insurance are considered noncomponents of the lease and therefore no consideration is allocated to them because they do not transfer a good or service to the customer. Fixed contractual payments from the Company’s leases are recognized on a straight-line basis over the terms of the respective leases. This means that, with respect to a particular lease, actual amounts billed in accordance with the lease during any given period may be higher or lower than the amount of rental revenue recognized for the period. Straight-line rental revenue is commenced when the tenant assumes control of the leased premises. Accrued straight-line rents receivable represents the amount by which straight-line rental revenue exceeds rents currently billed in accordance with lease agreements. Some of the Company’s leases are subject to annual changes in the Consumer Price Index (“CPI”). Although increases in CPI are not estimated as part of the Company’s measurement of straight-line rental revenue, for leases with base rent increases based on CPI, the amount of rent revenue recognized is adjusted in the period the changes in CPI are measured and effective. Additionally, some of the Company’s leases have extension options. Initial direct costs, primarily commissions, related to the leasing of our facilities are capitalized when material as incurred. Capitalized leasing costs are amortized on a straight-line basis over the remaining useful life of the respective leases. All other costs to negotiate or arrange a lease are expensed as incurred. Lease-related receivables, which include accounts receivable and accrued straight-line rents receivable, are reduced for credit losses, if applicable. To date the Company’s receivables have not had any credit losses. Such amounts would be recognized as a reduction to rental and other revenues. The Company regularly evaluates the collectability of its lease-related receivables. The Company’s evaluation of collectability primarily consists of reviewing past due account balances and considering such factors as the credit quality of our tenant, historical trends of the tenant and changes in tenant payment terms. If the Company’s assumptions regarding the collectability of lease-related receivables prove incorrect, the Company could experience credit losses in excess of what was recognized in rental and other revenues. The Company recognized $18,117 and $50,093 of rental and other revenues related to operating lease payments for the three and nine months ended September 30, 2019, respectively. Of these amounts $1,202 and $3,597 was for variable lease payments related to expense recoveries for the three and nine months ended September 30, 2019, respectively. The aggregate annual minimum cash to be received by the Company on the noncancelable operating leases related to its portfolio as of September 30, 2019 is as follows for the subsequent years ended December 31: 2019 (three months remaining) $ 16,507 2020 66,310 2021 64,947 2022 63,461 2023 62,040 Thereafter 391,576 Total $ 664,841 Information as Lessor Under ASC Topic 840 (As of and for the year ended December 31, 2018) The Company adopted the provisions of ASU 2014‑09 “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014‑09”) effective January 1, 2018 using the modified retrospective transition method. Rental income from leasing arrangements is specifically excluded from the standard. The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard. The Company’s operations consist of rental revenue earned from tenants under leasing arrangements which provide for minimum rent and escalations. These leases were accounted for as operating leases. For operating leases with contingent rental escalators, revenue was recorded based on the contractual cash rental payments due during the period. Revenue from leases with fixed annual rental escalators were recognized on a straight-line basis over the initial lease term, subject to a collectability assessment. If the Company determined that collectability of rents was not reasonably assured, future revenue recognition was limited to amounts contractually owed and paid, and, when appropriate, an allowance for estimated losses was established. The Company consistently assessed the need for an allowance for doubtful accounts, including an allowance for operating lease straight-line rent receivables, for estimated losses resulting from tenant defaults, or the inability of tenants to make contractual rent and tenant recovery payments. The Company also monitored the liquidity and creditworthiness of its tenants and operators on a continuous basis. This evaluation considered industry and economic conditions, property performance, credit enhancements and other factors. For operating lease straight-line rent amounts, the Company’s assessment was based on amounts estimated to be recoverable over the term of the lease. As of December 31, 2018, no allowance was recorded as it was not deemed necessary. The Company’s real estate assets are leased to tenants under operating leases. The minimum rental amounts under the leases were generally subject to scheduled fixed increases. The aggregate annual minimum cash to be received by the Company on its noncancelable operating leases as of December 31, 2018 were as follows: 2019 $ 50,527 2020 51,450 2021 49,926 2022 48,862 2023 47,743 Thereafter 330,180 Total $ 578,688 Information as Lessee Under ASC Topic 842 (As of and for the three and nine months ended September 30, 2019) The Company has four facilities subject to operating ground leases with a weighted average remaining term of 24 years. Rental payments on these leases are adjusted periodically based on either the CPI or on a pre-determined schedule. The monthly payments on a pre-determined schedule are recognized on a straight-line basis over the terms of the respective leases. Changes in the CPI are not estimated as part of our measurement of straight-line rental expense. Upon initial adoption of ASC Topic 842, the Company recognized a lease liability of $2.2 million (included in “Other Liabilities”) and a related right of use asset of $2.2 million (included in “Other Assets”) on our Condensed Consolidated Balance Sheets equal to the present value of the minimum lease payments required under each ground lease. During the nine months ended September 30, 2019, the Company recorded an additional $0.1 million right of use asset and recognized an additional lease liability of $0.1 million. The Company used a weighted average discount rate of approximately 4.4%, which was derived from our assessment of the credit quality of the Company and adjusted to reflect secured borrowing, estimated yield curves and long-term spread adjustments over appropriate tenors. Some of our ground leases contain extension options and, where we determined it was reasonably certain that an extension would occur, they were included in our calculation of the right of use asset and liability. We recognized approximately $35 and $66 of ground lease expense, which was paid in cash, during the three and nine months ended September 30, 2019 , respectively. The following table sets forth the undiscounted cash flows of our scheduled obligations for future minimum payments on operating ground leases at September 30, 2019 and a reconciliation of those cash flows to the operating lease liability at September 30, 2019: 2019 (three months remaining) $ 28 2020 116 2021 116 2022 116 2023 120 Thereafter 4,476 Total 4,972 Discount (2,593) Lease liability $ 2,379 Information as Lessee Under ASC Topic 840 (As of and for the year ended December 31, 2018) The Company acquired an interest, as ground lessee, in the ground lease related to the Omaha and Clermont facilities at their dates of acquisition. In connection with the acquisitions of the Moline facility the Company acquired the seller’s interest, as ground lessee, in an existing ground lease that has approximately 10 years remaining in the initial term, with 12 consecutive five-year renewal options. In connection with the acquisition of the Silvis facility the Company acquired the seller’s interest, as ground lessee, in an existing ground lease that has approximately 67 years remaining in the initial term, with no renewal options. The aggregate minimum cash payments to be made by the Company on these land leases as of December 31, 2018, were as follows: 2019 $ 109 2020 109 2021 109 2022 109 2023 113 Thereafter 2,121 Total $ 2,670

Rent Concentration

Rent Concentration	9 Months Ended
	Sep. 30, 2019
Rent Concentration
Rent Concentration	Note 9 – Rent Concentration The Company’s facilities with a concentration of rental revenue of 5% or greater is as follows for the periods below: Three Months Ended Nine Months Ended September 30, September 30, Facility 2019 2018 2019 2018 Encompass (four facilities and four locations) 10 % 11 % 10 % 12 % Belpre 8 11 8 7 OCOM 7 9 6 10 Sherman 5 6 5 6 Austin 5 6 5 7 Aggregate of all other facilities 65 57 66 58 Total 100 % 100 % 100 % 100 %

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies
Commitments and Contingencies	Note 10 – Commitments and Contingencies Litigation The Company is not presently subject to any material litigation nor, to its knowledge, is any material litigation threatened against the Company, which if determined unfavorably to the Company, would have a material adverse effect on the Company’s financial position, results of operations, or cash flows. Environmental Matters The Company follows a policy of monitoring its properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at its properties, the Company is not currently aware of any environmental liability with respect to its properties that would have a material effect on its financial position, results of operations, or cash flows. Additionally, the Company is not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that management believes would require additional disclosure or the recording of a loss contingency.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2019
Subsequent Events
Subsequent Events	Note 11 – Subsequent Events Subsequent events have been evaluated through November 7, 2019, the date the financial statements were issued. Interest Rate Swaps On October 3, 2019, the Company hedged its interest rate risk on the Term Loan by entering into two interest rate swaps with an aggregate notional amount of $130 million and a term of approximately five years, which effectively fixed the LIBOR component of the interest rate on a corresponding amount of the Term Loan at 1.21%.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies
Basis of presentation	Basis of presentation The accompanying condensed consolidated financial statements are unaudited and include the accounts of the Company, the Operating Partnership and its wholly-owned subsidiaries. The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual consolidated financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, the accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended December 31, 2018. In the opinion of management, all adjustments of a normal and recurring nature necessary for a fair presentation of the condensed consolidated financial statements for the interim periods have been made.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company, including the Operating Partnership and its wholly-owned subsidiaries. The Company presents the portion of any equity it does not own but controls (and thus consolidates) as noncontrolling interest. Noncontrolling interest in the Company includes the LTIP Units that have been granted to the Company’s and Advisor’s directors, officers and employees and the OP Units held by third parties. Refer to Note 5 – “Equity” and Note 7 – “Stock-Based Compensation” for additional information regarding the OP Units and LTIP Units. The Company classifies noncontrolling interest as a component of consolidated equity on its Condensed Consolidated Balance Sheets, separate from the Company’s total equity. The Company’s net income or loss is allocated to noncontrolling interests based on the respective ownership or voting percentage in the Operating Partnership associated with such noncontrolling interests and is removed from consolidated income or loss on the Condensed Consolidated Statements of Operations in order to derive net income or loss attributable to common stockholders. The noncontrolling ownership percentage is calculated by dividing the aggregate number of LTIP Units and OP Units held by third parties by the total number of shares of common stock, LTIP Units and OP Units outstanding. Any future issuances of additional shares of common stock, LTIP Units or OP Units could change the noncontrolling ownership interest.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Actual results could differ from those estimates.
Investment in Real Estate	Investment in Real Estate The Company determines when an acquisition meets the definition of a business or alternatively should be accounted for as an asset acquisition in accordance with ASU 2017-01 – “Business Combinations (Topic 805): Clarifying the Definition of a Business” (“ASU 2017-01”). ASU 2017-01 requires that, when substantially all of the fair value of an acquisition is concentrated in a single identifiable asset or a group of similar identifiable assets, the asset or group of similar identifiable assets does not meet the definition of a business and therefore is required to be accounted for as an asset acquisition. Transaction costs are capitalized for asset acquisitions and expensed as incurred for business combinations. ASU 2017-01 results in most, if not all, of the Company’s acquisitions being accounted for as asset acquisitions because substantially all of the fair value of the gross assets the Company acquires are concentrated in a single asset or group of similar identifiable assets. For asset acquisitions that are “owner occupied” (meaning that the seller either is the tenant or controls the tenant), the purchase price, including capitalized acquisition costs, will be allocated to land and building based on their relative fair values with no value allocated to intangible assets or liabilities. For asset acquisitions where there is a lease in place but not “owner occupied,” the Company will also allocate the purchase price to tangible assets and any intangible assets acquired or liabilities assumed based on their relative fair values. Real estate and related assets are stated net of accumulated depreciation. Renovations, replacements and other expenditures that improve or extend the life of assets are capitalized and depreciated over their estimated useful lives. Expenditures for ordinary maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful life of the buildings, which are generally between 23 and 50 years, tenant improvements, which are generally between one and 19 years, and site improvements, which are generally between three and 14 years.
Revenue Recognition	Revenue Recognition The Company’s operations primarily consist of rental revenue earned from tenants under leasing arrangements which provide for minimum rent and escalations. The leases have been accounted for as operating leases. For operating leases with contingent rental escalators, revenue is recorded based on the contractual cash rental payments due during the period. Revenue from leases with fixed annual rental escalators are recognized on a straight-line basis over the initial lease term, subject to a collectability assessment, with the difference between the contractual rental receipts and the straight-line amounts recorded as a “deferred rent receivable.” Additionally, rental revenue includes expense recoveries, which represents revenue recognized related to tenant reimbursement of real estate taxes, insurance, and certain other operating expenses. The Company recognizes these reimbursements and related expenses on a gross basis in its Condensed Consolidated Statements of Operations. Expenses required to be paid directly by the tenant are not subject to reimbursement. For all leases where rent collection has been deemed probable, the Company assesses the need for an allowance for doubtful accounts, including an allowance for operating lease straight-line rent receivables, for estimated losses resulting from tenant defaults, or the inability of tenants to make contractual rent and tenant recovery payments at each reporting date. The Company also monitors the liquidity and creditworthiness of its tenants and operators on a continuous basis. This evaluation considers industry and economic conditions, property performance, credit enhancements and other factors. For operating lease straight-line rent amounts, the Company's assessment is based on amounts estimated to be recoverable over the term of the lease. As of September 30, 2019 and December 31, 2018, based on the Company’s assessment, no allowance was recorded as one was not deemed necessary. However, because future events may adversely affect the Company’s tenants, a valuation allowance may need to be established in the future.
Cash and Cash Equivalents and Restricted Cash	Cash and Cash Equivalents and Restricted Cash The Company considers all demand deposits, cashier’s checks, money market accounts, and certificates of deposit with an original maturity of three months or less to be cash equivalents. Amounts included in restricted cash represent (1) certain security deposits received from tenants at the inception of their leases; (2) cash required to be held by a third-party lender as a reserve for debt service; and (3) funds held by the Company that were received from certain tenants that the Company collected to pay specific tenant expenses, such as real estate taxes and insurance, on the tenant’s behalf (“tenant reimbursements”). The following table provides a reconciliation of the Company’s cash and cash equivalents and restricted cash that sums to the total of those amounts at the end of the periods presented on the Company’s accompanying Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019 and 2018: As of September 30, 2019 2018 Cash and cash equivalents $ 2,815 $ 3,005 Restricted cash 3,011 817 Total cash and cash equivalents and restricted cash $ 5,826 $ 3,822
Escrow Deposits	Escrow Deposits The escrow deposits balance as of September 30, 2019 and December 31, 2018 was $2,865 and $1,752, respectively. Escrow deposits include funds held in escrow to be used for the acquisition of properties in the future and for the payment of taxes, insurance, and other amounts as stipulated by the Company’s Cantor Loan, as hereinafter defined.
Deferred Assets	Deferred Assets The deferred assets balance as of September 30, 2019 and December 31, 2018 was $13,307 and $9,352, respectively. The balance as of September 30, 2019 consisted of $13,020 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and $287 of other deferred costs. The balance as of December 31, 2018 consisted of $8,706 in deferred rent receivables resulting from the recognition of revenue from leases with fixed annual rental escalations on a straight-line basis and $646 of other deferred costs.
Other Assets	Other Assets The other assets balance was $4,363 as of September 30, 2019, which consisted of $3,094 for a right of use asset that was recorded in connection with the implementation of ASC Topic 842 on January 1, 2019 (refer to Note 8 – “Leases” for additional details), $930 in deferred preacquisition and construction in process costs, and $339 in a prepaid asset. The other assets balance was $322 as of December 31, 2018, which consisted of $139 in capitalized costs related to property acquisitions and $183 in a prepaid asset.
Security Deposits and Other	Security Deposits and Other The security deposits and other liability balance as of September 30, 2019 and December 31, 2018 was $6,362 and $4,152, respectively. The balance as of September 30, 2019 consisted of security deposits of $4,942 and a tenant impound liability of $1,420 related to amounts owed for specific tenant expenses. The balance as of December 31, 2018 consisted of security deposits of $3,272 and a tenant impound liability of $880 related to amounts owed for specific tenant expenses.
Derivative Instruments - Interest Rate Swaps	Derivative Instruments - Interest Rate Swaps As of September 30, 2019 and December 31, 2018, the Company had three interest rate swaps that were designated as cash flow hedges of interest rate risk. In accordance with the Company’s risk management strategy, the purpose of the interest rate swaps is to manage interest rate risk for a portion of the Company’s variable-rate debt. The interest rate swaps involve the Company’s receipt of variable-rate amounts from three counterparties in exchange for the Company making fixed-rate payments over the life of the agreement. The Company accounts for derivative instruments in accordance with the provisions of ASC Topic 815, “Derivatives and Hedging” and ASU No. 2017‑12, “Derivatives and Hedging: Targeted Improvements to Accounting for Hedging Activities.” As of September 30, 2019 and December 31, 2018, the Company’s liability balance related to these interest rate swaps was $10,399 and $3,487, respectively. Refer to Note 4 – “Credit Facility, Notes Payable and Derivative Instruments” for additional details regarding these interest rate swaps. Additionally, as discussed in Note 11 - "Subsequent Events," on October 3, 2019, the Company executed two additional interest rate swaps with a combined notional amount of $130 million.
Other Liability	Other Liability The Company adopted ASC Topic 842 on January 1, 2019, and had an other liability balance of $2,379 as of September 30, 2019, based on the provisions of that standard (refer to Note 8 – “Leases” for additional details).
Reclassification	Reclassification The Company reclassified the line item “Expense Recoveries” on its Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2018, of $884 and $2,610, respectively, to present this amount as a component of “Rental Revenue,” in order to conform to the current period presentation.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies
Schedule of Cash and Cash Equivalents and Restricted Cash	The following table provides a reconciliation of the Company’s cash and cash equivalents and restricted cash that sums to the total of those amounts at the end of the periods presented on the Company’s accompanying Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019 and 2018: As of September 30, 2019 2018 Cash and cash equivalents $ 2,815 $ 3,005 Restricted cash 3,011 817 Total cash and cash equivalents and restricted cash $ 5,826 $ 3,822

Property Portfolio (Tables)

Property Portfolio (Tables)	9 Months Ended
	Sep. 30, 2019
Schedule of Properties Acquired	A rollforward of the gross investment in land, building and improvements as of September 30, 2019 resulting from these acquisitions as well as other tenant improvements and the implementation of ASC 842 is as follows: Site & Tenant Acquired Lease Gross Investment in Land Building Improvements Intangible Assets Real Estate Balances as of December 31, 2018 $ 63,710 $ 518,451 $ 22,237 $ 43,152 $ 647,550 Facility Acquired – Date Acquired: Zachary – 2/28/19 — 3,336 512 835 4,683 Gilbert and Chandler – 3/19/19 4,616 11,643 — — 16,259 Las Vegas – 4/15/19 2,479 15,277 2,449 2,297 22,502 Oklahoma Northwest – 4/15/19 2,364 19,501 3,187 3,155 28,207 Mishawaka – 4/15/19 1,924 10,084 1,872 2,223 16,103 Surprise – 4/15/19 1,738 18,737 4,347 3,860 28,682 San Marcos – 7/12/19 2,322 6,934 530 2,188 11,974 Lansing – 8/1/19 1,202 7,681 852 1,633 11,368 Bannockburn – 8/5/19 731 3,419 1,214 1,325 6,689 Aurora – 8/6/19 1,521 7,446 911 2,679 12,557 Livonia – 8/14/19 980 7,629 643 1,340 10,592 Gilbert – 8/23/19 2,408 2,027 424 733 5,592 Morgantown – 9/26/19 883 5,286 879 902 7,950 ASC 842 Reclassification — — — (824) (824) Site and Tenant improvements (1) — — 508 — 508 Capitalized costs (2) — 54 — — 54 Total Additions: 23,168 119,054 18,328 22,346 182,896 Balances as of September 30, 2019 $ 86,878 $ 637,505 $ 40,565 $ 65,498 $ 830,446 (1) Represents tenant improvements that were completed and placed in service during the nine months ended September 30, 2019 related to the Sherman facility that was acquired in June 2017 and the Bountiful facility that was acquired in October 2018. Also includes site improvements at the Watertown facility that was acquired in September 2016. (2) Represents capitalized costs incurred during the nine months ended September 30, 2019 at the Derby facility that was acquired in August 2018. A rollforward of the gross investment in land, building and improvements as of September 30, 2018, resulting from these acquisitions is as follows: Site & Tenant Acquired Lease Gross Investment in Land Building Improvements Intangibles Real Estate Balances as of January 1, 2018 $ 42,701 $ 384,338 $ 12,818 $ 31,650 $ 471,507 Facility Acquired – Date Acquired: Moline / Silvis – 1/24/18 - 4,895 1,216 989 7,100 Freemont – 2/9/18 162 8,335 — — 8,497 Gainesville – 2/23/18 625 9,885 — — 10,510 Dallas – 3/1/18 6,272 17,012 — — 23,284 Orlando – 3/22/18 2,543 11,720 756 1,395 16,414 Belpre – 4/19/18 3,025 50,526 3,966 7,166 64,683 McAllen – 7/3/18 1,099 4,296 5,395 Derby – 8/3/18 412 2,496 243 453 3,604 Tenant improvements (1) — — 2,043 — 2,043 Total Additions : 14,138 109,165 8,224 10,003 141,530 Balances as of September 30, 2018 $ 56,839 $ 493,503 $ 21,042 $ 41,653 $ 613,037 (1) Represents tenant improvements that were completed and placed in service during the three months ended September 30, 2018 related to the Silvis and Sherman facilities that were acquired in January 2018 and June 2017, respectively. These amounts were recorded as construction-in-process within the “Other Assets” line item in the Company’s Consolidated Balance Sheet as of September 30, 2018, and reclassified to investment in real estate once completed.
Summary of Carrying amount of intangible assets and liabilities	The following is a summary of the carrying amount of intangible assets and liabilities as of the dates presented: As of September 30, 2019 Accumulated Cost Amortization Net Assets In-place leases $ 34,697 $ (6,599) $ 28,098 Above market leases 12,236 (1,991) 10,245 Leasing costs 18,565 (2,899) 15,666 $ 65,498 $ (11,489) $ 54,009 Liabilities Below market leases $ 3,855 $ (568) $ 3,287 As of December 31, 2018 Accumulated Cost Amortization Net Assets In-place leases $ 21,753 $ (4,037) $ 17,716 Above market ground lease 707 (28) 679 Above market leases 8,009 (1,096) 6,913 Leasing costs 12,683 (1,703) 10,980 $ 43,152 $ (6,864) $ 36,288 Liability Below market leases $ 2,336 $ (308) $ 2,028
Summary of the acquired lease intangible amortization	Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Amortization expense related to in-place leases $ 1,033 $ 647 $ 2,562 $ 1,797 Amortization expense related to leasing costs $ 467 $ 307 $ 1,195 $ 848 Decrease in rental revenue related to above market leases $ 343 $ 240 $ 895 $ 620 Increase in rental revenue related to below market leases $ 114 $ 56 $ 261 $ 152
Schedule of net amortization acquired lease intangible assets and liabilities	As of September 30, 2019, scheduled future aggregate net amortization of the acquired lease intangible assets and liabilities for each fiscal year ended December 31 is listed below: Net Decrease Net Increase in Revenue in Expenses 2019 (three months remaining) $ (246) $ 1,655 2020 (986) 6,601 2021 (988) 5,987 2022 (998) 5,620 2023 (1,024) 5,004 Thereafter (2,716) 18,897 Total $ (6,958) $ 43,764
Zachary Facility [Member]
Schedule of tangible and intangible assets	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 103 Building and tenant improvements 3,745 In-place leases 305 Above-market lease intangibles 117 Leasing costs 413 Below-market lease intangibles (34) Total purchase price $ 4,649
IRF Portfolio [Member]
Schedule of tangible and intangible assets	exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Oklahoma Las Vegas Surprise Northwest Mishawaka Land and site improvements $ 2,723 $ 1,966 $ 2,507 $ 1,998 Building and tenant improvements 17,482 22,856 22,545 11,882 In-place leases 1,778 1,845 1,890 1,465 Above-market lease intangibles — 938 367 236 Leasing costs 519 1,077 898 522 Below-market lease intangibles (863) — — — Total purchase price $ 21,639 $ 28,682 $ 28,207 $ 16,103
San Marcos [Member]
Schedule of tangible and intangible assets	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 2,448 Building and tenant improvements 7,338 In-place leases 698 Above-market lease intangibles 1,101 Leasing costs 389 Total purchase price $ 11,974
Lansing [Member]
Schedule of tangible and intangible assets	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 1,387 Building and tenant improvements 8,348 In-place leases 953 Above-market lease intangibles 130 Leasing costs 550 Below-market lease intangibles (248) Total purchase price $ 11,120
Bannockburn [Member]
Schedule of tangible and intangible assets	Land and site improvements $ 858 Building and tenant improvements 4,506 In-place leases 763 Above-market lease intangibles 240 Leasing costs 322 Below-market lease intangibles (138) Total purchase price $ 6,551
Aurora [Member]
Schedule of tangible and intangible assets	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 1,829 Building and tenant improvements 8,049 In-place leases 1,417 Above-market lease intangibles 861 Leasing costs 401 Total purchase price $ 12,557
Livonia [Member]
Schedule of tangible and intangible assets	Land and site improvements $ 1,181 Building and tenant improvements 8,071 In-place leases 1,252 Above-market lease intangibles 53 Leasing costs 35 Below-market lease intangibles (236) Total purchase price $ 10,356
Gilbert [Member]
Schedule of tangible and intangible assets	. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 2,470 Building and tenant improvements 2,389 In-place leases 121 Above-market lease intangibles 300 Leasing costs 312 Total purchase price $ 5,592
Morgantown [Member]
Schedule of tangible and intangible assets	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 1,256 Building and tenant improvements 5,792 In-place leases 457 Leasing costs 445 Total purchase price $ 7,950
Silvis facility [Member]
Schedule of tangible and intangible assets	The aggregate purchase price for the Moline/Silvis facilities was $6.9 million. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed for this acquisition: Site improvements $ 249 Building and tenant improvements 5,862 In-place leases 343 Above market ground lease intangibles 219 Leasing costs 427 Below market lease intangibles (229) Total purchase price $ 6,871
Orlando Facilities [Member]
Schedule of tangible and intangible assets	exclusive of tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,075 Building and tenant improvements 11,944 In-place leases 808 Above market lease intangibles 229 Leasing costs 358 Below market lease intangibles (10) Total purchase price $ 16,404
Belpre Portfolio [Member]
Schedule of tangible and intangible assets	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 3,997 Building and tenant improvements 53,520 In-place leases 2,660 Above market lease intangibles 2,527 Leasing costs 1,979 Below market lease intangibles (632) Total purchase price $ 64,051
Derby [Member]
Schedule of tangible and intangible assets	The following table presents the details of the tangible and intangible assets acquired and liabilities assumed: Land and site improvements $ 566 Building and tenant improvements 2,585 In-place leases 299 Above market lease intangibles Leasing costs 154 Below market lease intangibles (23) Total purchase price $ 3,581

Credit Facility, Notes Payabl_2

Credit Facility, Notes Payable and Derivative Instruments (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Instrument [Line Items]
Schedule of Outstanding borrowings	As of September 30, 2019 and December 31, 2018, the Company had the following outstanding borrowings under the Credit Facility: September 30, 2019 December 31, 2018 Revolver $ 67,225 $ 180,275 Term Loan 300,000 100,000 Less: Unamortized deferred financing costs (3,983) (3,922) Credit Facility, net $ 363,242 $ 276,353
Schedule of Aggregate balances of loans payable	The Company’s notes payable, net, includes two loans: (1) the Cantor Loan and (2) the West Mifflin Note, described in detail below. The following table sets forth the aggregate balances of these loans as of September 30, 2019 and December 31, 2018. September 30, 2019 December 31, 2018 Notes payable, gross $ 39,475 $ 39,475 Less: Unamortized debt discount (701) (799) Cumulative principal repayments (123) (22) Notes payable, net $ 38,651 $ 38,654
Schedule of comprehensive (Loss) income	The table below details the components of the loss presented on the accompanying Condensed Consolidated Statements of Comprehensive (Loss) Income recognized on the Company’s interest rate swaps designated as cash flow hedges for the three and nine months ended September 30, 2019 and 2018: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Amount of loss recognized in other comprehensive loss $ 1,603 $ 122 $ 7,559 $ 122 Amount of loss reclassified from accumulated other comprehensive loss into interest expense (300) (13) (684) (13) Total change in accumulated other comprehensive loss $ 1,303 $ 109 $ 6,875 $ 109
Cantor Loan [Member]
Debt Instrument [Line Items]
Schedule of Maturities of Long-term Debt	As of September 30, 2019, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2019 $ — 2020 — 2021 282 2022 447 2023 471 Thereafter 30,897 Total $ 32,097
West Mifflin Note Payable [Member]
Debt Instrument [Line Items]
Schedule of Maturities of Long-term Debt	As of September 30, 2019, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows: 2019 (three months remaining) $ 35 2020 7,220 Total $ 7,255

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2019
Preferred Stock [Member]
Schedule of Dividends Payable	Preferred stock dividend activity for the nine months ended September 30, 2019 is summarized in the following table: Applicable Quarterly Dividends Date Announced Record Date Quarter Payment Date Dividend per Share December 13, 2018 January 15, 2019 Q4 2018 January 31, 2019 $ 1,455 $ 0.46875 March 6, 2019 April 15, 2019 Q1 2019 April 30, 2019 $ 1,455 $ 0.46875 June 14, 2019 July 15, 2019 Q2 2019 July 31, 2019 $ 1,455 $ 0.46875 September 13, 2019 October 15, 2019 Q3 2019 October 31, 2019 $ (1) $ (1) Two months of this amount, equal to $970, was accrued at September 30, 2019. Preferred stock dividend activity for the nine months ended September 30, 2019 is summarized in the following table: Applicable Quarterly Dividends Date Announced Record Date Quarter Payment Date Dividend per Share December 13, 2018 January 15, 2019 Q4 2018 January 31, 2019 $ 1,455 $ 0.46875 March 6, 2019 April 15, 2019 Q1 2019 April 30, 2019 $ 1,455 $ 0.46875 June 14, 2019 July 15, 2019 Q2 2019 July 31, 2019 $ 1,455 $ 0.46875 September 13, 2019 October 15, 2019 Q3 2019 October 31, 2019 $ (1) $ (1) Two months of this amount, equal to $970, was accrued at September 30, 2019. Common stock dividend activity for the nine months ended September 30, 2019 is summarized in the following table: Applicable Dividend Dividends Date Announced Record Date Quarter Payment Date Amount (1) per Share December 13, 2018 December 26, 2018 Q4 2018 January 10, 2019 $ 5,695 $ 0.20 March 6, 2019 March 26, 2019 Q1 2019 April 10, 2019 $ 7,688 $ 0.20 June 14, 2019 June 26, 2019 Q2 2019 July 11, 2019 $ 7,699 $ 0.20 September 13, 2019 September 25, 2019 Q3 2019 October 10, 2019 $ $ 0.20 (1) Includes distributions on LTIP Units and OP Units.
Common Stock [Member]
Schedule of Dividends Payable	Preferred stock dividend activity for the nine months ended September 30, 2019 is summarized in the following table: Applicable Quarterly Dividends Date Announced Record Date Quarter Payment Date Dividend per Share December 13, 2018 January 15, 2019 Q4 2018 January 31, 2019 $ 1,455 $ 0.46875 March 6, 2019 April 15, 2019 Q1 2019 April 30, 2019 $ 1,455 $ 0.46875 June 14, 2019 July 15, 2019 Q2 2019 July 31, 2019 $ 1,455 $ 0.46875 September 13, 2019 October 15, 2019 Q3 2019 October 31, 2019 $ (1) $ (1) Two months of this amount, equal to $970, was accrued at September 30, 2019. Common stock dividend activity for the nine months ended September 30, 2019 is summarized in the following table: Applicable Dividend Dividends Date Announced Record Date Quarter Payment Date Amount (1) per Share December 13, 2018 December 26, 2018 Q4 2018 January 10, 2019 $ 5,695 $ 0.20 March 6, 2019 March 26, 2019 Q1 2019 April 10, 2019 $ 7,688 $ 0.20 June 14, 2019 June 26, 2019 Q2 2019 July 11, 2019 $ 7,699 $ 0.20 September 13, 2019 September 25, 2019 Q3 2019 October 10, 2019 $ $ 0.20 (1) Includes distributions on LTIP Units and OP Units.

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2019
Related Party Transactions
Schedule of due to related party, net	A rollforward of the due from related parties and due to related party balance, net, as of September 30, 2019 is as follows: Due From Related Parties Due to Related Party,Net Other Funds for Mgmt.Fees Funds due Due to Various due to from Related Purposes Advisor Advisor Party, net Balance as of January 1, 2019 $ 61 $ (1,143) 52 $ (1,091) Management fee expense incurred — (4,539) — (4,539) Management fees paid to Advisor — 4,060 — 4,060 Loans to Advisor — — (14) (14) Loans to other related parties 14 — — — Balance as of September 30, 2019 $ 75 $ (1,622) 38 $ (1,584)

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2019
Stock-Based Compensation
Schedule of time-based vesting LTIP unit activity	The time-based vesting LTIP unit activity under the Plan during the nine months ended September 30, 2019 was as follows: LTIP Units outstanding as of December 31, 2018 588 LTIP Units earned and granted via the 2018 performance program – Annual Awards (1) 108 LTIP Units granted on a discretionary basis related to the Annual Awards (2) 28 LTIP Units granted as 2019 long-term time based awards (3) 54 LTIP Units granted to independent directors of the Board (4) 22 LTIP Units – other grant and forfeitures, net (5) (9) LTIP Units outstanding as of September 30, 2019 791 (1) The 108 LTIP Units represents earned and granted units from the previously disclosed 2018 annual awards (the “Annual Awards”). On March 5, 2019 the Compensation Committee of the Board (the “Compensation Committee”) determined the extent to which the Company achieved the performance goals related to the 2018 Annual Awards and determined the number of LTIP Units that each grantee was entitled to receive. These grants vested 50% on March 5, 2019, the determination date, and 50% vest on March 5, 2020. (2) The 28 LTIP Units represents a discretionary grant by the Board. These grants vested 50% on March 5, 2019, the grant date, and 50% vest on March 5, 2020. (3) The 54 LTIP Units represent grants approved by the Board on March 5, 2019 pursuant to the Company' 2019 Long-Term Incentive Plan. These grants are valued based on the Company’s share price at the date of grant of $10.07 and vest in equal one-third increments on each of March 5, 2020, March 5, 2021, and March 5, 2022. (4) The 22 LTIP Units represent a grant to the independent directors of the Board made on May 29, 2019, which vest on May 29, 2020. (5) The decrease of nine LTIP Units net represents 11 LTIP Units redeemed for the Company’s common stock with a value of $110 and one LTIP Unit that was forfeited, partially offset by three LTIP Units that were granted on March 15, 2019 related to a new hire. These three LTIP Units vest in equal one-third increments on each of March 15, 2020, March 15, 2021, and March 5, 2022. A detail of the vested and unvested LTIP units outstanding as of September 30, 2019 is as follows: Total vested units 483 Unvested units: Granted to employees of the Advisor 286 Granted to the Company’s independent directors 22 Total unvested units 308 LTIP Units outstanding as of September 30, 2019 791
Schedule of of the Annual Awards and Long-Term Awards	A detail of the Annual Awards and Long-Term Awards under the 2017, 2018, and 2019 programs as of September 30, 2019 is as follows: 2017 Program 2018 Program 2019 Program Long-Term Annual Long-Term Annual Long-Term Total Net annual and long-term LTIP awards as of December 31, 2018 (at target) 96 161 110 — — 367 LTIP Unit target grants via the 2019 Performance Program – Annual Awards and Long-Term Awards (1) — — — 133 82 215 LTIP Units earned and granted via the 2018 Performance Program – Annual Awards (2) — (108) — — — (108) LTIP Units granted on a discretionary basis via the 2018 Performance Program – Annual Awards (2) — (28) — — — (28) LTIP Units not earned under the 2018 Performance Program – Annual Awards (3) — (25) — — — (25) Net annual and long-term LTIP awards as of September 30, 2019 (at target) 96 — 110 133 82 421 (1) These target Annual Awards and Long-Term Awards were approved by the Board on March 5, 2019. (2) These amounts represent grants from the 2018 program Annual Awards. Refer to the “Time-Based Grants” table above which presents these grants as earned and time-based. (3) On March 5, 2019 the Compensation Committee determined the extent to which the Company achieved the performance goals and concluded that these target awards were not achieved.
Schedule of of the assumptions for the Long-Term Awards using Monte Carlo simulations	Below are details regarding certain of the assumptions for the Long-Term Awards using Monte Carlo simulations: 2019 Long-Term 2018 Long-Term 2017 Long-Term Awards Awards Awards Share price $ 10.07 $ 8.86 $ 8.86 Target awards 82 110 96 Volatility 31.7 % 33.8 % 33.8% - 35.4% Risk-free rate 2.5 % 2.6 % 2.4% - 2.6% Dividend assumption reinvested reinvested reinvested Expected term in years 1.7 – 2.7

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Leases
Schedule of aggregate annual minimum cash to be received by the Company	The aggregate annual minimum cash to be received by the Company on the noncancelable operating leases related to its portfolio as of June 30, 2019 is as follows for the subsequent years ended December 31: 2019 (three months remaining) $ 16,507 2020 66,310 2021 64,947 2022 63,461 2023 62,040 Thereafter 391,576 Total $ 664,841 The Company’s real estate assets are leased to tenants under operating leases. The minimum rental amounts under the leases were generally subject to scheduled fixed increases. The aggregate annual minimum cash to be received by the Company on its noncancelable operating leases as of December 31, 2018 were as follows: 2019 $ 50,527 2020 51,450 2021 49,926 2022 48,862 2023 47,743 Thereafter 330,180 Total $ 578,688
Schedule of aggregate minimum cash payments to be made by the Company	The following table sets forth the undiscounted cash flows of our scheduled obligations for future minimum payments on operating ground leases at June 30, 2019 and a reconciliation of those cash flows to the operating lease liability at June 30, 2019: 2019 (three months remaining) $ 28 2020 116 2021 116 2022 116 2023 120 Thereafter 4,476 Total 4,972 Discount (2,593) Lease liability $ 2,379 The aggregate minimum cash payments to be made by the Company on these land leases as of December 31, 2018, were as follows: 2019 $ 109 2020 109 2021 109 2022 109 2023 113 Thereafter 2,121 Total $ 2,670

Rent Concentration (Tables)

Rent Concentration (Tables)	9 Months Ended
	Sep. 30, 2019
Rent Concentration
Schedule of concentration of rental revenue	The Company’s facilities with a concentration of rental revenue of 5% or greater is as follows for the periods below: Three Months Ended Nine Months Ended September 30, September 30, Facility 2019 2018 2019 2018 Encompass (four facilities and four locations) 10 % 11 % 10 % 12 % Belpre 8 11 8 7 OCOM 7 9 6 10 Sherman 5 6 5 6 Austin 5 6 5 7 Aggregate of all other facilities 65 57 66 58 Total 100 % 100 % 100 % 100 %

Organization (Details)

Organization (Details)	9 Months Ended
	Sep. 30, 2019
long-term incentive plan LTIP [Member]
Limited Liability Company (LLC) or Limited Partnership (LP), Members or Limited Partners, Ownership Interest	9.78%
Global Medical REIT GP LLC [Member]
Equity Method Investment, Ownership Percentage	90.22%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018	Dec. 31, 2017
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 2,815	$ 3,631	$ 3,005
Restricted cash	3,011	1,212	817
Total cash and cash equivalents and restricted cash	$ 5,826	$ 4,843	$ 3,822	$ 7,114

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Tenant Receivables		$ 4,167		$ 2,905
Escrow Deposit		2,865		1,752
Deferred Costs and Other Assets		13,307		9,352
Deferred Rent Receivables, Net		13,020		8,706
Security Deposit Liability		6,362		4,152
Other Assets		4,363		322
Other Deferred Costs, Net		287		646
Lease Deposit Liability		1,420		880
Accumulated Capitalized Interest Costs		54		139
Prepaid Expense and Other Assets		339		183
Derivative Liabilities		10,399		3,487
Operating Lease, Right-of-Use Asset		3,094
Other Liabilities		2,379
Reclassification from Expense Recoveries to Rental Revenue	$ 884		$ 2,610
Deferred preacquisition and construction in process costs		930
Accounting Standards Update 2017-02 [Member]
Other Liabilities		2,379
Interest Rate Swap [Member]
Derivative Liabilities		10,399		3,487
Building [Member]
Accumulated Capitalized Interest Costs		$ 54
Building [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life		50 years
Building [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life		23 years
Tenant improvements [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life		19 years
Tenant improvements [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life		1 year
Land Improvements [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life		14 years
Land Improvements [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life		3 years
Plano Lease [Member]
Security Deposit Liability		$ 4,942		$ 3,272

Property Portfolio - Gross Inve

Property Portfolio - Gross Investment (Details) - USD ($) $ in Thousands

Sep. 26, 2019

Aug. 23, 2019

Aug. 14, 2019

Aug. 06, 2019

Aug. 05, 2019

Aug. 01, 2019

Jul. 12, 2019

Aug. 03, 2018

Jul. 03, 2018

Mar. 01, 2018

Feb. 23, 2018

Feb. 09, 2018

Sep. 30, 2019

Sep. 30, 2018

Dec. 31, 2018

Property, Plant and Equipment [Line Items]

Beginning Balance

$ 647,550

$ 471,507

Site and tenant improvements

508

2,043

Capitalized costs

54

$ 139

Acquisitions

182,896

141,530

Ending Balance

830,446

613,037

Zachary [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

4,683

Gilbert and Chandler [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

16,259

Las Vegas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

22,502

Oklahoma Northwest [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

28,207

Mishawaka [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

16,103

Surprise [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

28,682

San Marcos [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 12,000

11,974

Lansing [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 11,100

11,368

Bannockburn [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 6,600

6,689

Aurora [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 12,600

12,557

Livonia [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 10,400

10,592

Gilbert [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 5,600

5,592

Morgantown [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 8,000

7,950

ASC 842 Reclassification [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

(824)

Moline / Silvis Facility [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

7,100

Freemont [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 8,500

8,497

Gainesville [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 10,500

10,510

Dallas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 23,300

23,284

Orlando [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

16,414

Belpre [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

64,683

McAllen [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 5,400

5,395

Derby [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 3,600

3,604

Land [Member]

Property, Plant and Equipment [Line Items]

Beginning Balance

63,710

42,701

Site and tenant improvements

0

0

Capitalized costs

0

Acquisitions

23,168

14,138

Ending Balance

86,878

56,839

Land [Member] | Zachary [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Land [Member] | Gilbert and Chandler [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

4,616

Land [Member] | Las Vegas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,479

Land [Member] | Oklahoma Northwest [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,364

Land [Member] | Mishawaka [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,924

Land [Member] | Surprise [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,738

Land [Member] | San Marcos [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,322

Land [Member] | Lansing [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,202

Land [Member] | Bannockburn [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

731

Land [Member] | Aurora [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,521

Land [Member] | Livonia [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

980

Land [Member] | Gilbert [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,408

Land [Member] | Morgantown [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

883

Land [Member] | ASC 842 Reclassification [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Land [Member] | Moline / Silvis Facility [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Land [Member] | Freemont [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

162

Land [Member] | Gainesville [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

625

Land [Member] | Dallas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

6,272

Land [Member] | Orlando [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,543

Land [Member] | Belpre [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

3,025

Land [Member] | McAllen [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,099

Land [Member] | Derby [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

412

Building [Member]

Property, Plant and Equipment [Line Items]

Beginning Balance

518,451

384,338

Site and tenant improvements

0

Capitalized costs

54

Acquisitions

119,054

109,165

Ending Balance

637,505

493,503

Building [Member] | Zachary [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

3,336

Building [Member] | Gilbert and Chandler [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

11,643

Building [Member] | Las Vegas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

15,277

Building [Member] | Oklahoma Northwest [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

19,501

Building [Member] | Mishawaka [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

10,084

Building [Member] | Surprise [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

18,737

Building [Member] | San Marcos [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

6,934

Building [Member] | Lansing [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

7,681

Building [Member] | Bannockburn [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

3,419

Building [Member] | Aurora [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

7,446

Building [Member] | Livonia [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

7,629

Building [Member] | Gilbert [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,027

Building [Member] | Morgantown [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

5,286

Building [Member] | ASC 842 Reclassification [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Building [Member] | Moline / Silvis Facility [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

4,895

Building [Member] | Freemont [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

8,335

Building [Member] | Gainesville [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

9,885

Building [Member] | Dallas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

17,012

Building [Member] | Orlando [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

11,720

Building [Member] | Belpre [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

50,526

Building [Member] | McAllen [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

4,296

Building [Member] | Derby [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,496

Building And Tenant Improvements [Member]

Property, Plant and Equipment [Line Items]

Beginning Balance

22,237

12,818

Site and tenant improvements

508

2,043

Capitalized costs

0

Acquisitions

18,328

8,224

Ending Balance

40,565

21,042

Building And Tenant Improvements [Member] | Zachary [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

512

Building And Tenant Improvements [Member] | Gilbert and Chandler [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Building And Tenant Improvements [Member] | Las Vegas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,449

Building And Tenant Improvements [Member] | Oklahoma Northwest [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

3,187

Building And Tenant Improvements [Member] | Mishawaka [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,872

Building And Tenant Improvements [Member] | Surprise [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

4,347

Building And Tenant Improvements [Member] | San Marcos [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

530

Building And Tenant Improvements [Member] | Lansing [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

852

Building And Tenant Improvements [Member] | Bannockburn [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,214

Building And Tenant Improvements [Member] | Aurora [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

911

Building And Tenant Improvements [Member] | Livonia [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

643

Building And Tenant Improvements [Member] | Gilbert [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

424

Building And Tenant Improvements [Member] | Morgantown [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

879

Building And Tenant Improvements [Member] | ASC 842 Reclassification [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Building And Tenant Improvements [Member] | Moline / Silvis Facility [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,216

Building And Tenant Improvements [Member] | Freemont [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Building And Tenant Improvements [Member] | Gainesville [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Building And Tenant Improvements [Member] | Dallas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Building And Tenant Improvements [Member] | Orlando [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

756

Building And Tenant Improvements [Member] | Belpre [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

3,966

Building And Tenant Improvements [Member] | McAllen [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Building And Tenant Improvements [Member] | Derby [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

243

Intangibles [Member]

Property, Plant and Equipment [Line Items]

Beginning Balance

43,152

31,650

Site and tenant improvements

0

0

Capitalized costs

0

Acquisitions

22,346

10,003

Ending Balance

65,498

41,653

Intangibles [Member] | Zachary [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

835

Intangibles [Member] | Gilbert and Chandler [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Intangibles [Member] | Las Vegas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,297

Intangibles [Member] | Oklahoma Northwest [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

3,155

Intangibles [Member] | Mishawaka [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,223

Intangibles [Member] | Surprise [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

3,860

Intangibles [Member] | San Marcos [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,188

Intangibles [Member] | Lansing [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,633

Intangibles [Member] | Bannockburn [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,325

Intangibles [Member] | Aurora [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

2,679

Intangibles [Member] | Livonia [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,340

Intangibles [Member] | Gilbert [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

733

Intangibles [Member] | Morgantown [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

902

Intangibles [Member] | ASC 842 Reclassification [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ (824)

Intangibles [Member] | Moline / Silvis Facility [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

989

Intangibles [Member] | Freemont [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Intangibles [Member] | Gainesville [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Intangibles [Member] | Dallas [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Intangibles [Member] | Orlando [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

1,395

Intangibles [Member] | Belpre [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

7,166

Intangibles [Member] | McAllen [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

0

Intangibles [Member] | Derby [Member]

Property, Plant and Equipment [Line Items]

Acquisitions

$ 453

Property Portfolio - Schedule o

Property Portfolio - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) $ in Thousands	Sep. 30, 2019USD ($)
Zachary Facility [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	$ 4,649
Zachary Facility [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	103
Zachary Facility [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3,745
Zachary Facility [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	305
Zachary Facility [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	117
Zachary Facility [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	413
Zachary Facility [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(34)
Las Vegas [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	21,639
Las Vegas [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,723
Las Vegas [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	17,482
Las Vegas [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,778
Las Vegas [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	0
Las Vegas [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	519
Las Vegas [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(863)
Surprise [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	28,682
Surprise [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,966
Surprise [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	22,856
Surprise [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,845
Surprise [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	938
Surprise [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,077
Surprise [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	0
Oklahoma Northwest [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	28,207
Oklahoma Northwest [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,507
Oklahoma Northwest [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	22,545
Oklahoma Northwest [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,890
Oklahoma Northwest [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	367
Oklahoma Northwest [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	898
Oklahoma Northwest [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	0
Mishawaka [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets	16,103
Mishawaka [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,998
Mishawaka [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	11,882
Mishawaka [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,465
Mishawaka [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	236
Mishawaka [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	522
Mishawaka [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	0
Orlando Facilities [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	16,404
Orlando Facilities [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3,075
Orlando Facilities [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	11,944
Orlando Facilities [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	808
Orlando Facilities [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	229
Orlando Facilities [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	358
Orlando Facilities [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(10)
Moline / Silvis Facility [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	6,871
Moline / Silvis Facility [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	249
Moline / Silvis Facility [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	5,862
Moline / Silvis Facility [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	343
Moline / Silvis Facility [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	219
Moline / Silvis Facility [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	427
Moline / Silvis Facility [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(229)
Belpre Portfolio [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	64,051
Belpre Portfolio [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3,997
Belpre Portfolio [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	53,520
Belpre Portfolio [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,660
Belpre Portfolio [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,527
Belpre Portfolio [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,979
Belpre Portfolio [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(632)
Derby [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3,581
Derby [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	566
Derby [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,585
Derby [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	299
Derby [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	154
Derby [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(23)
San Marcos [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	11,974
San Marcos [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,448
San Marcos [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	7,338
San Marcos [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	698
San Marcos [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,101
San Marcos [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	389
Lansing [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	11,120
Lansing [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,387
Lansing [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	8,348
Lansing [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	953
Lansing [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	130
Lansing [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	550
Lansing [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(248)
Bannockburn [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	6,551
Bannockburn [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	858
Bannockburn [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	4,506
Bannockburn [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	763
Bannockburn [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	240
Bannockburn [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	322
Bannockburn [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(138)
Aurora [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	12,557
Aurora [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,829
Aurora [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	8,049
Aurora [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,417
Aurora [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	861
Aurora [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	401
Livonia [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	10,356
Livonia [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,181
Livonia [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	8,071
Livonia [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,252
Livonia [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	53
Livonia [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	35
Livonia [Member] | Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Below Market Lease Intangibles	(236)
Gilbert [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	5,592
Gilbert [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,470
Gilbert [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	2,389
Gilbert [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	121
Gilbert [Member] | Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	300
Gilbert [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	312
Morgantown [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	7,950
Morgantown [Member] | Land and Site Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	1,256
Morgantown [Member] | Building And Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	5,792
Morgantown [Member] | In-place leases [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	457
Morgantown [Member] | Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	$ 445

Property Portfolio - Summary of

Property Portfolio - Summary of the carrying amount of intangible assets and liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Assets
Cost	$ 65,498	$ 43,152
Accumulated Amortization	(11,489)	(6,864)
Net	54,009	36,288
Liabilities
Cost	3,855	2,336
Accumulated Amortization	(568)	(308)
Net	3,287	2,028
In-place leases [Member]
Assets
Cost	34,697	21,753
Accumulated Amortization	(6,599)	(4,037)
Net	28,098	17,716
Above Market Ground Lease [Member]
Assets
Cost		707
Accumulated Amortization		(28)
Net		679
Above Market Lease intangibles [Member]
Assets
Cost	12,236	8,009
Accumulated Amortization	(1,991)	(1,096)
Net	10,245	6,913
Leasing Costs [Member]
Assets
Cost	18,565	12,683
Accumulated Amortization	(2,899)	(1,703)
Net	$ 15,666	$ 10,980

Property Portfolio - Summary _2

Property Portfolio - Summary of the acquired lease intangible amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
In-place leases [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 1,033	$ 647	$ 2,562	$ 1,797
Leasing Costs [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	467	307	1,195	848
Above Market Lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	343	240	895	620
Below Market Lease intangible [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 114	$ 56	$ 261	$ 152

Property Portfolio - Net amorti

Property Portfolio - Net amortization of the acquired lease intangible (Details) $ in Thousands	Sep. 30, 2019USD ($)
Net Decrease in Revenue
2019 (three months remaining)	$ (246)
2020	(986)
2021	(988)
2022	(998)
2023	(1,024)
Thereafter	(2,716)
Total	(6,958)
Net Increase in Expenses
2019 (three months remaining)	1,655
2020	6,601
2021	5,987
2022	5,620
2023	5,004
Thereafter	18,897
Total	$ 43,764

Property Portfolio - Additional

Property Portfolio - Additional Information (Details) $ in Thousands

Sep. 26, 2019USD ($)

Aug. 23, 2019USD ($)

Aug. 14, 2019USD ($)

Aug. 06, 2019USD ($)

Aug. 05, 2019USD ($)

Aug. 01, 2019USD ($)

Jul. 12, 2019USD ($)

Apr. 15, 2019USD ($)

Aug. 03, 2018USD ($)

Jul. 03, 2018USD ($)

Apr. 19, 2018USD ($)

Mar. 22, 2018USD ($)

Mar. 01, 2018USD ($)

Feb. 23, 2018USD ($)

Feb. 09, 2018USD ($)

Jan. 24, 2018USD ($)

Mar. 19, 2019USD ($)

Feb. 28, 2018USD ($)

Sep. 30, 2019USD ($)

Sep. 30, 2018USD ($)

Sep. 30, 2019USD ($)property

Sep. 30, 2018USD ($)

Feb. 28, 2019

Property, Plant and Equipment [Line Items]

Number of Properties Acquired | property

13

Depreciation, Total

$ 5,006

$ 3,614

$ 13,481

$ 9,965

Property, Plant and Equipment, Additions

182,896

141,530

Tenant Improvement Allowances Receivable

$ 19,137

$ 19,137

Operating Lease, Weighted Average Remaining Lease Term

24 years

24 years

Capital Lease Obligations, Noncurrent

$ 10,867

$ 10,867

Lease Intangibles Asset [Member]

Property, Plant and Equipment [Line Items]

Finite-Lived Intangible Asset, Useful Life

6 years 5 months 1 day

Lease Intangibles Liability [Member]

Property, Plant and Equipment [Line Items]

Finite-Lived Intangible Asset, Useful Life

6 years 4 months 28 days

Zachary Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 4,600

Lessor, Operating Lease, Term of Contract

46 years

Gilbert And Chandler Facility [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 16,300

Dobson Facility [Member]

Property, Plant and Equipment [Line Items]

Lessor, Operating Lease, Term of Contract

10 years 6 months

Moline Facility [Member]

Property, Plant and Equipment [Line Items]

Operating Lease, Weighted Average Remaining Lease Term

10 years

Fresenius Medical Care Quad Cities [Member]

Property, Plant and Equipment [Line Items]

Operating Lease, Weighted Average Remaining Lease Term

13 years

Quad Cities Nephrology Associates [Member]

Property, Plant and Equipment [Line Items]

Operating Lease, Weighted Average Remaining Lease Term

15 years

Silvis facility [Member]

Property, Plant and Equipment [Line Items]

Operating Lease, Weighted Average Remaining Lease Term

67 years

Fresenius [Member]

Property, Plant and Equipment [Line Items]

Operating Lease, Weighted Average Remaining Lease Term

13 years

Moline Silvis Facilities[Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 6,900

Freemont [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 8,500

8,497

Lessor, Operating Lease, Term of Contract

12 years

Gainesville [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 10,500

10,510

Lessor, Operating Lease, Term of Contract

12 years

Dallas [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 23,300

23,284

Orlando Facilities [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 16,400

Operating Lease, Weighted Average Remaining Lease Term

4 years 6 months

Belpre Portfolio [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 64,100

Operating Lease, Weighted Average Remaining Lease Term

11 years 4 months 6 days

McAllen [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 5,400

5,395

Lessor, Operating Lease, Term of Contract

11 years

IRF Portfolio [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 94,600

Operating Lease, Weighted Average Remaining Lease Term

8 years 3 months 18 days

San Marcos [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 12,000

$ 11,974

Operating Lease, Weighted Average Remaining Lease Term

8 years

Lansing [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 11,100

11,368

Operating Lease, Weighted Average Remaining Lease Term

8 years 6 months

Bannockburn [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 6,600

6,689

Operating Lease, Weighted Average Remaining Lease Term

6 years 3 months 18 days

Aurora [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 12,600

12,557

Operating Lease, Weighted Average Remaining Lease Term

6 years

Livonia [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 10,400

10,592

Operating Lease, Weighted Average Remaining Lease Term

3 years 2 months 12 days

Gilbert [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 5,600

5,592

Operating Lease, Weighted Average Remaining Lease Term

10 years

Morgantown [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 8,000

$ 7,950

Operating Lease, Weighted Average Remaining Lease Term

10 years

Derby [Member]

Property, Plant and Equipment [Line Items]

Property, Plant and Equipment, Additions

$ 3,600

$ 3,604

Operating Lease, Weighted Average Remaining Lease Term

9 years

LTAC Hospital [Member]

Property, Plant and Equipment [Line Items]

Lessor, Operating Lease, Term of Contract

16 years

Credit Facility, Notes Payabl_3

Credit Facility, Notes Payable and Derivative Instruments - Schedule of outstanding borrowings under the Credit Facility (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Long-term Line of Credit	$ 363,242	$ 276,353
Less: Unamortized deferred financing costs	(701)	(799)
Revolving Credit Facility [Member]
Long-term Line of Credit	67,225	180,275
Term Loan [Member]
Long-term Line of Credit	300,000	100,000
Revolving credit facility [Member]
Less: Unamortized deferred financing costs	$ (3,983)	$ (3,922)

Credit Facility, Notes Payabl_4

Credit Facility, Notes Payable and Derivative Instruments - Schedule of net of unamortized discount balances (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Credit Facility, Notes Payable and Derivative Instruments
Notes payable, gross	$ 39,475	$ 39,475
Less: Unamortized debt discount	(701)	(799)
Cumulative principal repayment	(123)	(22)
Notes payable, net	$ 38,651	$ 38,654

Credit Facility, Notes Payabl_5

Credit Facility, Notes Payable and Derivative Instruments - Scheduled Principal Payments Due On Cantor Loan Note Payable (Details) - Cantor Loan [Member] - USD ($) $ in Thousands	Sep. 30, 2019	Mar. 31, 2016
Debt Instrument [Line Items]
2019 (six months remaining)	$ 0
2020	0
2021	282
2022	447
2023	471
Thereafter	30,897
Total	$ 32,097	$ 32,097

Credit Facility, Notes Payabl_6

Credit Facility, Notes Payable and Derivative Instruments - Scheduled Principal Payments Due On West Mifflin Note Payable (Details) - West Mifflin Note Payable [Member] - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018	Sep. 25, 2015
Debt Instrument [Line Items]
2019 (six months remaining)	$ 35
2020	7,220
Total	$ 7,255	$ 7,356	$ 7,378

Credit Facility, Notes Payabl_7

Credit Facility, Notes Payable and Derivative Instruments - Schedule of interest rate swap agreement (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Credit Facility, Notes Payable and Derivative Instruments
Amount of loss recognized in other comprehensive loss	$ 1,603	$ 122	$ 7,559	$ 122
Amount of loss reclassified from accumulated other comprehensive loss into interest expense	(300)	(13)	(684)	(13)
Total change in accumulated other comprehensive loss	$ 1,303	$ 109	$ 6,875	$ 109

Credit Facility, Notes Payabl_8

Credit Facility, Notes Payable and Derivative Instruments - Additional Information (Details) - USD ($) $ in Thousands	Aug. 07, 2018	Nov. 16, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Sep. 29, 2019	Apr. 15, 2019	Mar. 31, 2016	Sep. 25, 2015
Debt Instrument [Line Items]
Amortization of Financing Costs			$ 32	$ 33	$ 98	$ 98
Other Operating Activities, Cash Flow Statement					164,450	142,900
Increase (Decrease) in Security Deposits					2,210	1,800
Repayments of Lines of Credit					$ 77,500	10,400
Debt, Weighted Average Interest Rate			4.19%		4.19%		4.64%
Debt Instrument, Term					3 years 10 months 6 days		4 years 2 months 27 days
Long-term Debt, Gross			$ 39,475		$ 39,475		$ 39,475
Line Of Credit Cash Paid Other					924	2,750
Additional Interest Expense					2,193
Interest Expense, Total			4,549	4,055	12,707	10,681
EBITDAR					6,000
Minimum Net Worth Required for Compliance			203,795		$ 203,795
Net Proceeds raised Through Equity Offerings, Percent					75.00%
Extension option (in years)					1 year 5 months 13 days
Sun Trust Bank [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate		2.93%
Citizens Bank of Pennsylvania [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate		2.93%
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative, Amount of Hedged Item	$ 100,000
Debt Instrument, Basis Spread on Variable Rate	2.88%
Derivative Instruments in Hedges, Liabilities, at Fair Value			10,399		$ 10,399		3,487
Interest Rate Swap [Member] | Sun Trust Bank [Member]
Debt Instrument [Line Items]
Derivative, Amount of Hedged Item		$ 40,000
Interest Rate Swap [Member] | Citizens Bank of Pennsylvania [Member]
Debt Instrument [Line Items]
Derivative, Amount of Hedged Item		$ 30,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Amortization of Financing Costs			303	455	863	1,373
Increase (Decrease) in Security Deposits			3,716	3,211	10,268	7,872
Long-term Debt, Gross			86,950	132,500	86,950	132,500
Cantor Loan [Member]
Debt Instrument [Line Items]
Long-term Debt, Total			32,097		32,097					$ 32,097
Debt Instrument, Interest Rate, Stated Percentage										5.22%
Interest Expense, Total			429	428	1,271	1,271
West Mifflin Note Payable [Member]
Debt Instrument [Line Items]
Long-term Debt, Total			7,255		7,255		$ 7,356				$ 7,378
Debt Instrument, Interest Rate, Stated Percentage											3.72%
Interest Expense, Debt			69	$ 72	207	$ 211
Repayments of Notes Payable					101
The Revolver [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount			50,000		50,000				$ 200,000
The Term loan [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount			300,000		300,000			$ 175,000
The Term loan [Member] | Revolving Credit Facility [Member] | Interest Rate Swap [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount			300,000		300,000
Accordion [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount			75,000		75,000				$ 150,000
Reallocation from / (to) another debt instrument			$ 150,000		$ 150,000

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Dividend Amount	$ 9,470	$ 6,981
Preferred Stock [Member] | Dividend Declared On 13 12 18 [Member]
Dividend Amount	$ 1,455
Dividends per Share	$ 0.46875
Preferred Stock [Member] | Dividend Declared On 03 06 19 [Member]
Dividend Amount	$ 1,455
Dividends per Share	$ 0.46875
Preferred Stock [Member] | Dividend Declared On June142019 [Member]
Dividend Amount	$ 1,455
Dividends per Share	$ 0.46875
Preferred Stock [Member] | Dividend Declared On 13 09 19 [Member]
Dividend Amount	$ 1,455
Dividends per Share	$ 0.46875
Common Stock [Member] | Dividend Declared On 13 12 18 [Member]
Dividend Amount	$ 5,695
Dividends per Share	$ 0.20
Common Stock [Member] | Dividend Declared On 03 06 19 [Member]
Dividend Amount	$ 7,688
Dividends per Share	$ 0.20
Common Stock [Member] | Dividend Declared On June142019 [Member]
Dividend Amount	$ 7,699
Dividends per Share	$ 0.20
Common Stock [Member] | Dividend Declared On 13 09 19 [Member]
Dividend Amount	$ 8,004
Dividends per Share	$ 0.20

Equity - Additional Information

Equity - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands	1 Months Ended		3 Months Ended	9 Months Ended		12 Months Ended
	Mar. 18, 2019	Aug. 17, 2018	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Preferred Stock, Shares Authorized				10,000		10,000
Preferred Stock, Par or Stated Value Per Share				$ 0.001		$ 0.001
Preferred Stock, Shares Issued				3,105		3,105
Common Stock, Shares Authorized				500,000		500,000
Common Stock, Par or Stated Value Per Share				$ 0.001		$ 0.001
Preferred Stock, Redemption Price Per Share				$ 25
Common Stock, Shares, Outstanding				36,290		25,944
Dividends Payable				$ 9,470,000		$ 6,981,000
Preferred Stock, Liquidation Preference Per Share				$ 25
Limited Partners' Capital Account, Units Issued						1,899
Payments of dividens, Common Stock, OP and LTIP Units				$ (21,167,000)	$ (14,075,000)
Partners' Capital Account, Units, Sale of Units				49
Limited Partners' Capital Account				$ 27,881,000		$ 27,894,000
Proceeds from Issuance of Common Stock	$ 75,191,000			$ 96,799,000	3,209,000
Shares Issued, Price Per Share				$ 10.73
Payments of Dividends, Total				$ 4,365,000	4,366,000
Noncontrolling Interest, Increase from Subsidiary Equity Issuance				506,000	4,742,000
Stock To Be Issued During Period Value ATM Offering		$ 50,000,000		$ 3,143,000		3,145,000
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs			$ 302,000		302,000
Partners' Capital Account, Units, Treasury Units Purchased				51
Partners' Capital Account, Treasury Units, Purchased				$ 519,000
Dividend Accrued				970,000
IPO [Member]
Noncontrolling Interest, Increase from Subsidiary Equity Issuance				$ 506		16,363,000
At The Market [Member]
Stock Issued During Period, Shares, New Issues				2,051
Common Stock [Member]
Dividends Payable			180,000	$ 265,000	180,000
Proceeds from Issuance of Common Stock				21,608,000
Payments of Dividends, Total				85,000	46,000
Noncontrolling Interest, Increase from Subsidiary Equity Issuance				$ 0	0
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs			$ 0		$ 0
Series A Preferred Stock [Member]
Common Stock, Shares, Outstanding				3,105
Dividends Payable, Amount Per Share				$ 1.875
Preferred Stock, Liquidation Preference Per Share				$ 25
Preferred Stock, Dividend Rate, Percentage				7.50%
Long Tem Incentives Plan Units [Member]
Dividends Payable				$ 496,000		$ 316,000

Related Party Transactions - Re

Related Party Transactions - Related Party Balances (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Related Party Transaction [Line Items]
Balance, Beginning			$ 1,091
Balance, Beginning			(1,030)
Management fee expense incurred	$ (1,621)	$ (1,104)	(4,539)	$ (3,280)
Management fees paid to Advisor			4,060
Loans to other related parties				$ 49
Balance, Ending	(1,584)		(1,584)
Balance, Ending	1,584		1,584
Advisor [Member]
Related Party Transaction [Line Items]
Loans to Advisor			(14)
Funds for Various Purposes [Member]
Related Party Transaction [Line Items]
Balance, Beginning			(61)
Balance, Ending	(75)		(75)
Funds for Various Purposes [Member] | Other related parties [Member]
Related Party Transaction [Line Items]
Loans to other related parties			14
Mgmt Fees Due To Advisor [Member]
Related Party Transaction [Line Items]
Balance, Beginning			1,143
Balance, Beginning			(1,143)
Management fee expense incurred	(1,621)		(4,539)
Management fees paid to Advisor			4,060
Balance, Ending	(1,622)		(1,622)
Balance, Ending	1,622		1,622
Funds Due from Advisor [Member]
Related Party Transaction [Line Items]
Balance, Beginning			(52)
Loans to Advisor			(14)
Balance, Ending	$ (38)		$ (38)

Related Party Transactions - Ad

Related Party Transactions - Additional information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	May 08, 2017
Related Party Transaction [Line Items]
Management Fee Expense	$ 1,621	$ 1,104	$ 4,539	$ 3,280
Loans to other related parties				49
Due to Related Parties	1,584		$ 1,584		$ 1,030
Percentage of Management Fees attributable to Shareholders			1.50%
Mgmt Fees Due To Advisor [Member]
Related Party Transaction [Line Items]
Management Fee Expense	1,621		$ 4,539
Payment for Management Fee		$ 1,104		$ 3,280
Due to Related Parties	$ 1,622		$ 1,622		$ 1,143
Mr Jamie Barber [Member]
Related Party Transaction [Line Items]
Accrued Salaries, Current						$ 125

Stock-Based Compensation - Time

Stock-Based Compensation - Time-based vesting (Details) - shares		Mar. 05, 2019	Apr. 15, 2019	Sep. 30, 2019
LTIP Units outstanding as of June 30, 2019				791,000
Long Tem Incentives Plan Units [Member]
LTIP units granted		28	3
Long Tem Incentives Plan Units [Member] | Equity Incentive Plan 2016 [Member]
LTIP units outstanding as of December 31, 2018				588,000
LTIP units redeemed in cash or forfeited	[1]			(9,000)
LTIP Units outstanding as of June 30, 2019				791,000
Long Tem Incentives Plan Units [Member] | 2018 Performance Program [Member]
LTIP units granted	[2]			108,000
Long Tem Incentives Plan Units [Member] | Discretionary [Member]
LTIP units granted	[3]			28,000
Long Tem Incentives Plan Units [Member] | 2019 Time Based
LTIP units granted	[4]			54,000
Long Tem Incentives Plan Units [Member] | Independent directors [Member]
LTIP units granted	[5]			22,000
[1]	The decrease of nine LTIP Units net represents 11 LTIP Units redeemed for the Company’s common stock with a value of $110 and one LTIP Unit that was forfeited, partially offset by three LTIP Units that were granted on March 15, 2019 related to a new hire. These three LTIP Units vest in equal one-third increments on each of March 15, 2020, March 15, 2021, and March 5, 2022.
[2]	The 108 LTIP Units represents earned and granted units from the previously disclosed 2018 annual awards (the “Annual Awards”). On March 5, 2019 the Compensation Committee of the Board (the “Compensation Committee”) determined the extent to which the Company achieved the performance goals related to the 2018 Annual Awards and determined the number of LTIP Units that each grantee was entitled to receive. These grants vested 50% on March 5, 2019, the determination date, and 50% vest on March 5, 2020.
[3]	The 28 LTIP Units represents a discretionary grant by the Board. These grants vested 50% on March 5, 2019, the grant date, and 50% vest on March 5, 2020.
[4]	The 54 LTIP Units represent grants approved by the Board on March 5, 2019 pursuant to the Company' 2019 Long-Term Incentive Plan. These grants are valued based on the Company’s share price at the date of grant of $10.07 and vest in equal one-third increments on each of March 5, 2020, March 5, 2021, and March 5, 2022.The 22 LTIP Units represent a grant to the independent directors of the Board made on May 29, 2019, which vest on May 29, 2020.
[5]	The 22 LTIP Units represent a grant to the independent directors of the Board made on May 29, 2019, which vest on May 29, 2020.

Stock-Based Compensation - Vest

Stock-Based Compensation - Vested and unvested LTIP units (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2019shares
Total vested units	483
Unvested units:
Total unvested units	308
LTIP units outstanding as of December 31, 2018	791
Advisor [Member]
Unvested units:
Granted	286
Independent directors [Member]
Unvested units:
Granted	22

Stock-Based Compensation - Long

Stock-Based Compensation - Long-Term Awards (Details)	9 Months Ended
	Sep. 30, 2019shares
Net annual and long-term LTIP awards as of March 31, 2019 (at target)	421
Total Annual Long term Awards [Member]
Net annual and long-term LTIP awards as of December 31, 2018 (at target)	367
2017 Long-Term Awards | Long-Term Awards [Member]
Net annual and long-term LTIP awards as of December 31, 2018 (at target)	96
Net annual and long-term LTIP awards as of March 31, 2019 (at target)	96
2018 Long-Term Awards | Annual Awards [Member]
Net annual and long-term LTIP awards as of December 31, 2018 (at target)	161
LTIP Units earned and granted under the 2018 Performance Program - Annual Awards	(108)	[1]
LTIP unit forfeitures	(25)	[2]
2018 Long-Term Awards | Long-Term Awards [Member]
Net annual and long-term LTIP awards as of December 31, 2018 (at target)	110
Net annual and long-term LTIP awards as of March 31, 2019 (at target)	110
2018 Long-Term Awards | Total Annual Long term Awards [Member]
LTIP Units earned and granted under the 2018 Performance Program - Annual Awards	(108)	[1],[3]
LTIP unit forfeitures	(25)	[2]
2018 Long-Term Awards | Discretionary [Member] | Annual Awards [Member]
LTIP Units earned and granted under the 2018 Performance Program - Annual Awards	(28)	[1]
2018 Long-Term Awards | Discretionary [Member] | Total Annual Long term Awards [Member]
LTIP Units earned and granted under the 2018 Performance Program - Annual Awards	(28)	[1]
2019 Program [Member] | Annual Awards [Member]
LTIP Unit target grants via the 2019 Performance Program	133	[3]
Net annual and long-term LTIP awards as of March 31, 2019 (at target)	133
2019 Program [Member] | Long-Term Awards [Member]
LTIP Unit target grants via the 2019 Performance Program	82	[3]
Net annual and long-term LTIP awards as of March 31, 2019 (at target)	82
2019 Program [Member] | Total Annual Long term Awards [Member]
LTIP Unit target grants via the 2019 Performance Program	215	[3]
[1]	These amounts represent grants from the 2018 program Annual Awards. Refer to the “Time-Based Grants” table above which presents these grants as earned and time-based.
[2]	On March 5, 2019 the Compensation Committee determined the extent to which the Company achieved the performance goals and concluded that these target awards were not achieved.
[3]	These target Annual Awards and Long-Term Awards were approved by the Board on March 5, 2019.

Stock-Based Compensation - Assu

Stock-Based Compensation - Assumptions Long-Term Awards (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Target awards | shares	110
2019 Long-Term Awards
Adoption date price | $ / shares	$ 10.07
Target awards | shares	82
Volatility	31.70%
Risk-free rate	2.50%
Dividend assumption	reinvested
Expected term in years	3 years
2018 Long-Term Awards
Adoption date price | $ / shares	$ 8.86
Volatility	33.80%
Risk-free rate	2.60%
Dividend assumption	reinvested
Expected term in years	2 years 8 months 12 days
2017 Long-Term Awards
Adoption date price | $ / shares	$ 8.86
Target awards | shares	96
Dividend assumption	reinvested
2017 Long-Term Awards | Maximum [Member]
Volatility	35.40%
Risk-free rate	2.60%
Expected term in years	2 years 8 months 12 days
2017 Long-Term Awards | Minimum [Member]
Volatility	33.80%
Risk-free rate	2.40%
Expected term in years	1 year 8 months 12 days

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($)	Mar. 05, 2021	Mar. 05, 2020	Mar. 05, 2019	Apr. 15, 2019	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Share-based Compensation					$ 868,000	$ 741,000	$ 2,493,000	$ 1,978,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage							100.00%
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized					$ 3,500		$ 3,500
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition							1 year 6 months
Performance Goals For Awards							100%
Additional Earn Up Rate For Grantee							150.00%
2017 Long-Term Awards
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%	50.00%
2018 Time Based Awards
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value		$ 10.07
Long Tem Incentives Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%	50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted			28	3
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other Grant And Forfeitures				9
Conversion of Stock, Amount Converted				$ 110
Long Tem Incentives Plan Units [Member] | 2016 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					1,020,000		1,020,000
Common Stock, Capital Shares Reserved for Future Issuance					2,232,000		2,232,000
Long Tem Incentives Plan Units [Member] | 2018 Long-Term Awards
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted									108
Long-Term Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate							0.00%
Long-Term Awards [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%
Long-Term Awards [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			50.00%
Long-Term Awards [Member] | Long Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate					200.00%		200.00%
Long-Term Awards [Member] | 2018 Long-Term Awards | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			50.00%
Long-Term Awards [Member] | 2018 Long-Term Awards | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%

Leases - Aggregate annual minim

Leases - Aggregate annual minimum cash to be received by the Company on the noncancelable operating leases (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Leases
2019 (three months remaining)	$ 16,507	$ 50,527
2020	66,310	51,450
2021	64,947	49,926
2022	63,461	48,862
2023	62,040	47,743
Thereafter	391,576	330,180
Total	$ 664,841	$ 578,688

Leases - Scheduled obligations

Leases - Scheduled obligations for future minimum payments on operating ground leases (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Leases
2019 (three months remaining)	$ 28	$ 109
2020	116	109
2021	116	109
2022	116	109
2023	120	113
Thereafter	4,476	2,121
Total	4,972	$ 2,670
Discount	(2,593)
Lease liability	$ 2,379

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Jan. 24, 2018
Operating Lease Average Remaining Lease Term			10 years
Operating Lease, Lease Income	$ 18,117	$ 13,995	$ 50,093	$ 38,790
Operating Lease, Variable Lease Income	$ 1,202		$ 3,597
Operating Lease, Weighted Average Remaining Lease Term	24 years		24 years
Operating Lease, Right-of-Use Asset	$ 3,094		$ 3,094
Operating Lease, Weighted Average Discount Rate, Percent	4.40%		4.40%
Operating Lease, Expense	$ 35		$ 66
Other Liabilities	$ 2,379		2,379
Increase In Operating Lease Right Of Use Assets			100
Increase In Operating Lease Liabilities			$ 100
Moline Facility [Member]
Operating Lease, Weighted Average Remaining Lease Term						10 years
Lessee Operating Lease Remaining Term Of Contract					10 years
Lessor, Operating Lease, Renewal Term					12 years
Silvis facility [Member]
Operating Lease, Weighted Average Remaining Lease Term						67 years
Lessee Operating Lease Remaining Term Of Contract					67 years

Rent Concentration (Details)

Rent Concentration (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Concentration Risk, Percentage	100.00%	100.00%	100.00%	100.00%
Encompass [Member]
Concentration Risk, Percentage	10.00%	11.00%	10.00%	12.00%
Belpre [Member]
Concentration Risk, Percentage	8.00%	11.00%	8.00%	7.00%
OCOM [Member]
Concentration Risk, Percentage	7.00%	9.00%	6.00%	10.00%
Sherman [Member]
Concentration Risk, Percentage	5.00%	6.00%	5.00%	6.00%
Austin [Member]
Concentration Risk, Percentage	5.00%	6.00%	5.00%	7.00%
All Other Facilities [Member]
Concentration Risk, Percentage	65.00%	57.00%	66.00%	58.00%

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - The Term loan [Member] - Interest Rate Swap [Member] $ in Millions	Oct. 03, 2019USD ($)item
Subsequent Event [Line Items]
Number of interest rate swaps entered | item	2
Aggregate notional amount | $	$ 130
Term of the instrument	5 years
Interest rate (as a percent)	1.21%